{"componentChunkName":"component---src-templates-country-template-js","path":"/dz/","result":{"pageContext":{"globalAvg":{"2015":{"policyAreaScores":{},"adoptionCount":{"adopted":0,"partial":0,"not adopted":0,"null":0}},"2016":{"policyAreaScores":{},"adoptionCount":{"adopted":0,"partial":0,"not adopted":0,"null":0}},"2017":{"policyAreaScores":{"all":49.55342529810612,"Clinical and treatment":65.80450148809524,"Overall":49.55342529810612,"Testing and prevention":36.89855390008764,"Structural":48.36616347569957,"Health systems":51.243386243386254},"adoptionCount":{"adopted":8.603092783505154,"partial":3.149484536082474,"not adopted":8.902061855670103,"null":12.345360824742269}},"2018":{"policyAreaScores":{"all":53.02858034599604,"Clinical and treatment":68.46245421245422,"Overall":53.02858034599604,"Testing and prevention":41.29213483146068,"Structural":48.59362215676649,"Health systems":60.82251082251082},"adoptionCount":{"adopted":9.695876288659793,"partial":2.829896907216495,"not adopted":8.938144329896907,"null":11.536082474226804}},"2019":{"policyAreaScores":{"all":54.53850788781767,"Clinical and treatment":69.3614001892148,"Overall":54.53850788781767,"Testing and prevention":44.82804232804232,"Structural":49.24122484045166,"Health systems":58.76921634795651},"adoptionCount":{"adopted":10.994845360824742,"partial":3.2938144329896906,"not adopted":9.149484536082474,"null":9.561855670103093}},"2020":{"policyAreaScores":{"all":60.56664768548178,"Clinical and treatment":75.6856261022928,"Overall":60.56664768548178,"Testing and prevention":49.672448979591856,"Structural":58.13717067583047,"Health systems":62.60750360750363},"adoptionCount":{"adopted":11.948453608247423,"partial":3.8350515463917527,"not adopted":6.917525773195877,"null":10.29896907216495}},"2021":{"policyAreaScores":{"all":60.32596835788328,"Clinical and treatment":74.06328320802005,"Overall":60.32596835788328,"Testing and prevention":55.459882583170256,"Structural":51.30952380952383,"Health systems":66.01759175007584},"adoptionCount":{"adopted":11.6340206185567,"partial":3.5309278350515463,"not adopted":7.603092783505154,"null":10.231958762886597}},"2022":{"policyAreaScores":{"all":60.14702350935331,"Clinical and treatment":75.58840749414522,"Overall":60.14702350935331,"Testing and prevention":53.7594696969697,"Structural":51.54107347406318,"Health systems":65.53113553113555},"adoptionCount":{"adopted":12.427835051546392,"partial":3.902061855670103,"not adopted":7.917525773195877,"null":8.75257731958763}},"2023":{"policyAreaScores":{"all":60.236474317412295,"Clinical and treatment":75.58840749414522,"Overall":60.236474317412295,"Testing and prevention":54.16531385281387,"Structural":51.47766323024057,"Health systems":65.53113553113555},"adoptionCount":{"adopted":12.443298969072165,"partial":3.9072164948453607,"not adopted":7.891752577319588,"null":8.757731958762887}},"2024":{"policyAreaScores":{"all":60.243828494584925,"Clinical and treatment":75.58840749414522,"Overall":60.243828494584925,"Testing and prevention":54.1298024891775,"Structural":51.53493699885455,"Health systems":65.53113553113555},"adoptionCount":{"adopted":12.443298969072165,"partial":3.902061855670103,"not adopted":7.896907216494846,"null":8.757731958762887}},"recent":{"policyAreaScores":{"all":57.097938144329895,"Clinical and treatment":69.18449197860963,"Overall":58.126009100249505,"Testing and prevention":52.880763416477706,"Structural":50.48795205367373,"Health systems":60.2928444104915},"adoptionCount":{"adopted":13.907216494845361,"partial":5.489690721649485,"not adopted":9.422680412371134,"null":4.180412371134021}},"years":{"adoptionCount":{"adopted":0,"partial":0,"not adopted":0,"null":33}}},"regionalAvg":{"Asia and the Pacific":{"2017":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2.7857142857142856,"partial":1.5555555555555556,"not adopted":2.2666666666666666,"null":3.7435897435897436},"Overall":{"adopted":2.467741935483871,"partial":1.4470588235294117,"not adopted":2.979020979020979,"null":3.1},"Testing and prevention":{"adopted":2.242424242424242,"partial":1.3157894736842106,"not adopted":3.6153846153846154,"null":2.5806451612903225},"Structural":{"adopted":2.95,"partial":1.6875,"not adopted":4.0256410256410255,"null":1.775},"Health systems":{"adopted":1.565217391304348,"partial":1,"not adopted":1.7142857142857142,"null":4.2}},"policyAreaScores":{"Clinical and treatment":52.56802721088435,"Overall":42.06830206830207,"Testing and prevention":34.527027027027025,"Structural":44.23611111111111,"Health systems":38.302469135802475}},"2018":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2.388888888888889,"partial":1.1333333333333333,"not adopted":1.7142857142857142,"null":4.333333333333333},"Overall":{"adopted":2.5725806451612905,"partial":1.411764705882353,"not adopted":2.839160839160839,"null":3.5642857142857145},"Testing and prevention":{"adopted":2.608695652173913,"partial":1.3333333333333333,"not adopted":3.55,"null":3.925925925925926},"Structural":{"adopted":3.3,"partial":1.7,"not adopted":4.051282051282051,"null":1.7352941176470589},"Health systems":{"adopted":1.64,"partial":1.1428571428571428,"not adopted":1.6111111111111112,"null":4.125}},"policyAreaScores":{"Clinical and treatment":60.077160493827165,"Overall":43.95095238095237,"Testing and prevention":26.23015873015873,"Structural":46.791666666666664,"Health systems":47.99242424242423}},"2019":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2.717948717948718,"partial":1.0588235294117647,"not adopted":2.03125,"null":3.4473684210526314},"Overall":{"adopted":2.6911764705882355,"partial":1.5324675324675325,"not adopted":2.8533333333333335,"null":2.935251798561151},"Testing and prevention":{"adopted":2.6923076923076925,"partial":1.5333333333333334,"not adopted":3.575,"null":4},"Structural":{"adopted":3.4,"partial":1.875,"not adopted":3.975,"null":1.125},"Health systems":{"adopted":1.7419354838709677,"partial":1.3076923076923077,"not adopted":1.605263157894737,"null":3.7}},"policyAreaScores":{"Clinical and treatment":59.50076804915514,"Overall":45.99751605476796,"Testing and prevention":30.978835978835978,"Structural":46.731150793650784,"Health systems":49.86111111111111}},"2020":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.393939393939394,"partial":1.1578947368421053,"not adopted":1.9411764705882353,"null":5.275862068965517},"Overall":{"adopted":2.923076923076923,"partial":1.4767441860465116,"not adopted":2.4656488549618323,"null":3.769230769230769},"Testing and prevention":{"adopted":2.4074074074074074,"partial":1.4444444444444444,"not adopted":3.1025641025641026,"null":3.375},"Structural":{"adopted":3.5,"partial":1.6333333333333333,"not adopted":2.3947368421052633,"null":3},"Health systems":{"adopted":2.1,"partial":1.5789473684210527,"not adopted":2.108108108108108,"null":3.7586206896551726}},"policyAreaScores":{"Clinical and treatment":75.12175324675326,"Overall":52.15196461098101,"Testing and prevention":34.619708994709,"Structural":58.64236111111111,"Health systems":46.577380952380956}},"2021":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.8636363636363638,"partial":1.4705882352941178,"not adopted":2.1176470588235294,"null":6.214285714285714},"Overall":{"adopted":2.9672131147540983,"partial":1.5679012345679013,"not adopted":2.6076923076923078,"null":3.874015748031496},"Testing and prevention":{"adopted":2.8461538461538463,"partial":1.5714285714285714,"not adopted":2.4864864864864864,"null":4.551724137931035},"Structural":{"adopted":3.45,"partial":1.7419354838709677,"not adopted":3.6,"null":1.6842105263157894},"Health systems":{"adopted":1.911764705882353,"partial":1.368421052631579,"not adopted":1.8611111111111112,"null":3.8125}},"policyAreaScores":{"Clinical and treatment":68.02678571428571,"Overall":52.279463407781975,"Testing and prevention":46.91468253968254,"Structural":49.09424603174604,"Health systems":51.1231884057971}},"2022":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.173913043478261,"partial":1.4736842105263157,"not adopted":2.0625,"null":5.821428571428571},"Overall":{"adopted":3.078740157480315,"partial":1.5517241379310345,"not adopted":2.732824427480916,"null":3.5161290322580645},"Testing and prevention":{"adopted":2.6774193548387095,"partial":1.7647058823529411,"not adopted":2.717948717948718,"null":3.8846153846153846},"Structural":{"adopted":3.55,"partial":1.625,"not adopted":3.7,"null":1.5263157894736843},"Health systems":{"adopted":2.121212121212121,"partial":1.3157894736842106,"not adopted":1.9722222222222223,"null":3.5625}},"policyAreaScores":{"Clinical and treatment":70.75396825396825,"Overall":50.612359190988215,"Testing and prevention":40.1901455026455,"Structural":49.12896825396825,"Health systems":51.04056437389771}},"2023":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.173913043478261,"partial":1.4736842105263157,"not adopted":2.0625,"null":5.821428571428571},"Overall":{"adopted":3.078740157480315,"partial":1.5632183908045978,"not adopted":2.7251908396946565,"null":3.5161290322580645},"Testing and prevention":{"adopted":2.6774193548387095,"partial":1.8235294117647058,"not adopted":2.6923076923076925,"null":3.8846153846153846},"Structural":{"adopted":3.55,"partial":1.625,"not adopted":3.7,"null":1.5263157894736843},"Health systems":{"adopted":2.121212121212121,"partial":1.3157894736842106,"not adopted":1.9722222222222223,"null":3.5625}},"policyAreaScores":{"Clinical and treatment":70.75396825396825,"Overall":50.681163594470036,"Testing and prevention":40.363756613756614,"Structural":49.186011904761905,"Health systems":51.04056437389771}},"2024":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.173913043478261,"partial":1.4736842105263157,"not adopted":2.0625,"null":5.821428571428571},"Overall":{"adopted":3.078740157480315,"partial":1.5632183908045978,"not adopted":2.7251908396946565,"null":3.5161290322580645},"Testing and prevention":{"adopted":2.6774193548387095,"partial":1.8235294117647058,"not adopted":2.6923076923076925,"null":3.8846153846153846},"Structural":{"adopted":3.55,"partial":1.625,"not adopted":3.7,"null":1.5263157894736843},"Health systems":{"adopted":2.121212121212121,"partial":1.3157894736842106,"not adopted":1.9722222222222223,"null":3.5625}},"policyAreaScores":{"Clinical and treatment":70.75396825396825,"Overall":50.681163594470036,"Testing and prevention":40.363756613756614,"Structural":49.186011904761905,"Health systems":51.04056437389771}},"recent":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.5,"partial":1.52,"not adopted":2.2162162162162162,"null":2.727272727272727},"Overall":{"adopted":3.0596026490066226,"partial":1.7327586206896552,"not adopted":3.0324675324675323,"null":2.317073170731707},"Testing and prevention":{"adopted":2.973684210526316,"partial":1.6551724137931034,"not adopted":3.375,"null":3},"Structural":{"adopted":3.475,"partial":1.9714285714285715,"not adopted":4.1,"null":1.0769230769230769},"Health systems":{"adopted":2.121212121212121,"partial":1.7037037037037037,"not adopted":2.324324324324324,"null":3}},"policyAreaScores":{"Clinical and treatment":59.552005012531346,"Overall":48.69459905174192,"Testing and prevention":45.934065934065934,"Structural":46.7986111111111,"Health systems":42.503217503217506}}},"Eastern Europe and central Asia":{"2017":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.5,"partial":1.6666666666666667,"not adopted":1.8571428571428572,"null":3.4},"Overall":{"adopted":2.6140350877192984,"partial":1.5135135135135136,"not adopted":2.6545454545454548,"null":2.95},"Testing and prevention":{"adopted":2.076923076923077,"partial":1.4444444444444444,"not adopted":3.625,"null":2.3076923076923075},"Structural":{"adopted":3.3125,"partial":1.6923076923076923,"not adopted":3.4375,"null":1.875},"Health systems":{"adopted":1.4285714285714286,"partial":1,"not adopted":1.25,"null":4.125}},"policyAreaScores":{"Clinical and treatment":75.37698412698411,"Overall":51.66629230308475,"Testing and prevention":34.90646258503402,"Structural":49.485367063492056,"Health systems":50.303030303030305}},"2018":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2.8,"partial":1,"not adopted":1.5384615384615385,"null":3.8},"Overall":{"adopted":2.8225806451612905,"partial":1.4473684210526316,"not adopted":2.5084745762711864,"null":2.9411764705882355},"Testing and prevention":{"adopted":2.6666666666666665,"partial":1.7,"not adopted":3.5625,"null":2.3333333333333335},"Structural":{"adopted":3.75,"partial":1.6923076923076923,"not adopted":3.375,"null":1.7142857142857142},"Health systems":{"adopted":2.0625,"partial":1.1666666666666667,"not adopted":1.2142857142857142,"null":3.4375}},"policyAreaScores":{"Clinical and treatment":67.11805555555554,"Overall":56.17240646258502,"Testing and prevention":43.48015873015873,"Structural":52.63764880952381,"Health systems":65.06410256410255}},"2019":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.266666666666667,"partial":1,"not adopted":2,"null":2.3846153846153846},"Overall":{"adopted":3.129032258064516,"partial":1.5609756097560976,"not adopted":2.6551724137931036,"null":2.36734693877551},"Testing and prevention":{"adopted":2.7333333333333334,"partial":1.5555555555555556,"not adopted":3.6875,"null":3.5},"Structural":{"adopted":3.75,"partial":2.3076923076923075,"not adopted":3.466666666666667,"null":1.125},"Health systems":{"adopted":1.8125,"partial":1.125,"not adopted":1.3125,"null":3.3125}},"policyAreaScores":{"Clinical and treatment":72.2576530612245,"Overall":56.44909688013135,"Testing and prevention":44.023809523809526,"Structural":52.99479166666668,"Health systems":58.01282051282052}},"2020":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4,"partial":1.5833333333333333,"not adopted":1.6923076923076923,"null":3.8333333333333335},"Overall":{"adopted":3.274193548387097,"partial":1.6521739130434783,"not adopted":2.0172413793103448,"null":2.869565217391304},"Testing and prevention":{"adopted":2.857142857142857,"partial":1.3333333333333333,"not adopted":2.0714285714285716,"null":3.357142857142857},"Structural":{"adopted":3.625,"partial":1.8461538461538463,"not adopted":2.466666666666667,"null":2.7333333333333334},"Health systems":{"adopted":2.5625,"partial":1.75,"not adopted":1.8125,"null":1.9090909090909092}},"policyAreaScores":{"Clinical and treatment":69.91758241758241,"Overall":60.51755447941887,"Testing and prevention":57.5,"Structural":58.72395833333332,"Health systems":57.301587301587325}},"2021":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.230769230769231,"partial":1.5833333333333333,"not adopted":1.8181818181818181,"null":4.25},"Overall":{"adopted":3.406779661016949,"partial":1.6521739130434783,"not adopted":2.5,"null":2.5813953488372094},"Testing and prevention":{"adopted":3,"partial":1.5,"not adopted":3.1333333333333333,"null":3.857142857142857},"Structural":{"adopted":4.125,"partial":1.9333333333333333,"not adopted":3.066666666666667,"null":1.2666666666666666},"Health systems":{"adopted":2.375,"partial":1.4545454545454546,"not adopted":1.8,"null":2.3846153846153846}},"policyAreaScores":{"Clinical and treatment":68.67559523809526,"Overall":57.0077312534209,"Testing and prevention":45.76955782312924,"Structural":56.987847222222214,"Health systems":58.11011904761906}},"2022":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.230769230769231,"partial":1.6153846153846154,"not adopted":1.8181818181818181,"null":4.571428571428571},"Overall":{"adopted":3.35,"partial":1.7872340425531914,"not adopted":2.456140350877193,"null":2.575},"Testing and prevention":{"adopted":3.1333333333333333,"partial":1.8571428571428572,"not adopted":2.9375,"null":4.2},"Structural":{"adopted":3.75,"partial":2.125,"not adopted":3.1333333333333333,"null":1.2666666666666666},"Health systems":{"adopted":2.4375,"partial":1.4545454545454546,"not adopted":1.7333333333333334,"null":2.3846153846153846}},"policyAreaScores":{"Clinical and treatment":68.67559523809526,"Overall":57.85613397901533,"Testing and prevention":51.170634920634924,"Structural":54.505208333333336,"Health systems":59.36011904761906}},"2023":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.230769230769231,"partial":1.6153846153846154,"not adopted":1.8181818181818181,"null":4.571428571428571},"Overall":{"adopted":3.3666666666666667,"partial":1.7708333333333333,"not adopted":2.4210526315789473,"null":2.575},"Testing and prevention":{"adopted":3.2,"partial":1.75,"not adopted":2.8125,"null":4.2},"Structural":{"adopted":3.75,"partial":2.125,"not adopted":3.1333333333333333,"null":1.2666666666666666},"Health systems":{"adopted":2.4375,"partial":1.4545454545454546,"not adopted":1.7333333333333334,"null":2.3846153846153846}},"policyAreaScores":{"Clinical and treatment":68.67559523809526,"Overall":58.17393058918482,"Testing and prevention":52.420634920634924,"Structural":54.505208333333336,"Health systems":59.36011904761906}},"2024":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.230769230769231,"partial":1.6153846153846154,"not adopted":1.8181818181818181,"null":4.571428571428571},"Overall":{"adopted":3.3666666666666667,"partial":1.7708333333333333,"not adopted":2.4210526315789473,"null":2.575},"Testing and prevention":{"adopted":3.2,"partial":1.75,"not adopted":2.8125,"null":4.2},"Structural":{"adopted":3.75,"partial":2.125,"not adopted":3.1333333333333333,"null":1.2666666666666666},"Health systems":{"adopted":2.4375,"partial":1.4545454545454546,"not adopted":1.7333333333333334,"null":2.3846153846153846}},"policyAreaScores":{"Clinical and treatment":68.67559523809526,"Overall":58.17393058918482,"Testing and prevention":52.420634920634924,"Structural":54.505208333333336,"Health systems":59.36011904761906}},"recent":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4,"partial":1.7692307692307692,"not adopted":2.1538461538461537,"null":4.25},"Overall":{"adopted":3.3870967741935485,"partial":2.04,"not adopted":2.5833333333333335,"null":1.967741935483871},"Testing and prevention":{"adopted":3.3333333333333335,"partial":1.875,"not adopted":3.25,"null":3.6666666666666665},"Structural":{"adopted":3.9375,"partial":2.3125,"not adopted":3.1333333333333333,"null":1},"Health systems":{"adopted":2.3125,"partial":2.076923076923077,"not adopted":1.75,"null":1.8181818181818181}},"policyAreaScores":{"Clinical and treatment":61.36904761904762,"Overall":55.68996415770608,"Testing and prevention":50.027777777777786,"Structural":55.48611111111111,"Health systems":55.87797619047621}}},"Middle East and North Africa":{"2017":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2.7333333333333334,"partial":1.4545454545454546,"not adopted":1.3076923076923077,"null":4.3},"Overall":{"adopted":2,"partial":1.3421052631578947,"not adopted":3.3,"null":3.7333333333333334},"Testing and prevention":{"adopted":1.8571428571428572,"partial":1.1111111111111112,"not adopted":3.736842105263158,"null":3.533333333333333},"Structural":{"adopted":1.6666666666666667,"partial":1.6666666666666667,"not adopted":5.55,"null":2.45},"Health systems":{"adopted":1.2,"partial":1.1111111111111112,"not adopted":1.7777777777777777,"null":4.6}},"policyAreaScores":{"Clinical and treatment":69.02777777777779,"Overall":31.471674876847295,"Testing and prevention":23.634453781512608,"Structural":21.636904761904766,"Health systems":18.055555555555568}},"2018":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":1.9411764705882353,"partial":1,"not adopted":1.4,"null":5.2},"Overall":{"adopted":1.7857142857142858,"partial":1.2702702702702702,"not adopted":3.338235294117647,"null":3.763157894736842},"Testing and prevention":{"adopted":1.8333333333333333,"partial":1.1666666666666667,"not adopted":3.45,"null":3.4444444444444446},"Structural":{"adopted":1.9411764705882353,"partial":1.5714285714285714,"not adopted":5.75,"null":1.6666666666666667},"Health systems":{"adopted":1.2,"partial":1.125,"not adopted":1.6111111111111112,"null":4.5}},"policyAreaScores":{"Clinical and treatment":69.16666666666664,"Overall":36.02749433106575,"Testing and prevention":23.77976190476191,"Structural":25.478174603174594,"Health systems":40.74074074074074}},"2019":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2.526315789473684,"partial":1,"not adopted":1.5625,"null":4},"Overall":{"adopted":2,"partial":1.3714285714285714,"not adopted":3.1486486486486487,"null":3.48},"Testing and prevention":{"adopted":2.0833333333333335,"partial":1.1428571428571428,"not adopted":3.4,"null":3.933333333333333},"Structural":{"adopted":1.8888888888888888,"partial":1.8461538461538463,"not adopted":5.55,"null":1.55},"Health systems":{"adopted":1.1,"partial":1.125,"not adopted":1.6111111111111112,"null":4.55}},"policyAreaScores":{"Clinical and treatment":66.61111111111113,"Overall":37.62533068783068,"Testing and prevention":24.306722689075627,"Structural":26.84027777777777,"Health systems":38.541666666666664}},"2020":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2.75,"partial":1.2727272727272727,"not adopted":2,"null":4},"Overall":{"adopted":2.1636363636363636,"partial":1.3076923076923077,"not adopted":2.732394366197183,"null":3.7468354430379747},"Testing and prevention":{"adopted":2.4285714285714284,"partial":1.25,"not adopted":2.8947368421052633,"null":3.9},"Structural":{"adopted":1.9411764705882353,"partial":1.4545454545454546,"not adopted":3.5,"null":4.05},"Health systems":{"adopted":1.6666666666666667,"partial":1.2222222222222223,"not adopted":2.263157894736842,"null":3.05}},"policyAreaScores":{"Clinical and treatment":62.67361111111109,"Overall":37.00847763347763,"Testing and prevention":25.000000000000007,"Structural":33.77380952380953,"Health systems":34.70588235294116}},"2021":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3,"partial":1.6,"not adopted":1.4444444444444444,"null":6.555555555555555},"Overall":{"adopted":1.92,"partial":1.2258064516129032,"not adopted":2.8125,"null":4.613333333333333},"Testing and prevention":{"adopted":1.8,"partial":1,"not adopted":2.111111111111111,"null":5.882352941176471},"Structural":{"adopted":1.95,"partial":1.3076923076923077,"not adopted":4.95,"null":2.25},"Health systems":{"adopted":1.3846153846153846,"partial":1,"not adopted":1.7647058823529411,"null":4.15}},"policyAreaScores":{"Testing and prevention":39.42708333333333,"Overall":36.77292768959435,"Structural":30.307539682539687,"Health systems":37.291666666666664,"Clinical and treatment":57.142857142857146}},"2022":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.111111111111111,"partial":1.5714285714285714,"not adopted":1.4,"null":5.944444444444445},"Overall":{"adopted":2.1636363636363636,"partial":1.2972972972972974,"not adopted":2.9242424242424243,"null":4.054054054054054},"Testing and prevention":{"adopted":2.076923076923077,"partial":1.1428571428571428,"not adopted":2.3333333333333335,"null":5.1875},"Structural":{"adopted":2,"partial":1.4285714285714286,"not adopted":5.2,"null":1.8},"Health systems":{"adopted":1.8461538461538463,"partial":1,"not adopted":1.8333333333333333,"null":3.7}},"policyAreaScores":{"Testing and prevention":41.720779220779214,"Overall":41.281820904462414,"Structural":30.218253968253975,"Health systems":44.06249999999999,"Clinical and treatment":69.94047619047619}},"2023":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.111111111111111,"partial":1.5714285714285714,"not adopted":1.4,"null":5.944444444444445},"Overall":{"adopted":2.125,"partial":1.3243243243243243,"not adopted":2.953846153846154,"null":4.054054054054054},"Testing and prevention":{"adopted":2,"partial":1.2857142857142858,"not adopted":2.3529411764705883,"null":5.1875},"Structural":{"adopted":1.95,"partial":1.4285714285714286,"not adopted":5.25,"null":1.8},"Health systems":{"adopted":1.8461538461538463,"partial":1,"not adopted":1.8333333333333333,"null":3.7}},"policyAreaScores":{"Testing and prevention":41.42316017316018,"Overall":41.010407307577125,"Structural":29.662698412698422,"Health systems":44.06249999999999,"Clinical and treatment":69.94047619047619}},"2024":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.111111111111111,"partial":1.5714285714285714,"not adopted":1.4,"null":5.944444444444445},"Overall":{"adopted":2.1454545454545455,"partial":1.3243243243243243,"not adopted":2.9242424242424243,"null":4.054054054054054},"Testing and prevention":{"adopted":2.076923076923077,"partial":1.2857142857142858,"not adopted":2.2777777777777777,"null":5.1875},"Structural":{"adopted":1.95,"partial":1.4285714285714286,"not adopted":5.25,"null":1.8},"Health systems":{"adopted":1.8461538461538463,"partial":1,"not adopted":1.8333333333333333,"null":3.7}},"policyAreaScores":{"Testing and prevention":41.42316017316018,"Overall":41.010407307577125,"Structural":29.662698412698422,"Health systems":44.06249999999999,"Clinical and treatment":69.94047619047619}},"recent":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.4210526315789473,"partial":1.5333333333333334,"not adopted":2.066666666666667,"null":2.411764705882353},"Overall":{"adopted":2.4571428571428573,"partial":1.6363636363636365,"not adopted":3.472972972972973,"null":2.1363636363636362},"Testing and prevention":{"adopted":2.4375,"partial":1.5454545454545454,"not adopted":3.7,"null":2.5},"Structural":{"adopted":2.05,"partial":1.8,"not adopted":5.65,"null":1.1176470588235294},"Health systems":{"adopted":1.8,"partial":1.6428571428571428,"not adopted":2.0526315789473686,"null":2.55}},"policyAreaScores":{"Clinical and treatment":63.29034391534391,"Overall":41.704260651629056,"Testing and prevention":34.61904761904762,"Structural":30.06249999999999,"Health systems":40.92592592592593}}},"Western and central Europe and North America":{"2017":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":1.84,"partial":1.4285714285714286,"not adopted":1.875,"null":5.794871794871795},"Overall":{"adopted":2.7007874015748032,"partial":1.2586206896551724,"not adopted":1.823008849557522,"null":4.34640522875817},"Testing and prevention":{"adopted":2.423076923076923,"partial":1.1,"not adopted":2,"null":4.694444444444445},"Structural":{"adopted":4.743589743589744,"partial":1.3571428571428572,"not adopted":2.111111111111111,"null":2.3333333333333335},"Health systems":{"adopted":1.3243243243243243,"partial":1,"not adopted":1.3125,"null":4.589743589743589}},"policyAreaScores":{"Structural":68.29721204721204,"Overall":59.07561728395063,"Testing and prevention":49.5467032967033,"Health systems":51.153846153846146,"Clinical and treatment":58.333333333333336}},"2018":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2,"partial":1,"not adopted":1.3846153846153846,"null":5.641025641025641},"Overall":{"adopted":2.808219178082192,"partial":1.2884615384615385,"not adopted":1.7327586206896552,"null":4.006578947368421},"Testing and prevention":{"adopted":2.861111111111111,"partial":1,"not adopted":1.78125,"null":3.675675675675676},"Structural":{"adopted":4.717948717948718,"partial":1.5357142857142858,"not adopted":2.3157894736842106,"null":1.9736842105263157},"Health systems":{"adopted":1.4864864864864864,"partial":1,"not adopted":1.1515151515151516,"null":4.684210526315789}},"policyAreaScores":{"Structural":65.25234025234025,"Overall":65.53649237472767,"Testing and prevention":61.856499356499356,"Health systems":66.76587301587303,"Clinical and treatment":74.99999999999999}},"2019":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2.1842105263157894,"partial":1.25,"not adopted":1.4166666666666667,"null":5.3076923076923075},"Overall":{"adopted":2.879194630872483,"partial":1.3396226415094339,"not adopted":1.956896551724138,"null":3.7086092715231787},"Testing and prevention":{"adopted":2.6944444444444446,"partial":1,"not adopted":1.90625,"null":3.9714285714285715},"Structural":{"adopted":4.948717948717949,"partial":1.5666666666666667,"not adopted":2.769230769230769,"null":1.0769230769230769},"Health systems":{"adopted":1.5555555555555556,"partial":1,"not adopted":1.2424242424242424,"null":4.526315789473684}},"policyAreaScores":{"Structural":62.06756206756207,"Overall":63.36203575281245,"Testing and prevention":60.670849420849414,"Health systems":63.918650793650805,"Clinical and treatment":72.92063492063492}},"2020":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3,"partial":1.25,"not adopted":1.25,"null":4.90625},"Overall":{"adopted":3.5675675675675675,"partial":1.4074074074074074,"not adopted":1.62,"null":3.551470588235294},"Testing and prevention":{"adopted":3.111111111111111,"partial":1.2173913043478262,"not adopted":1.92,"null":3.5428571428571427},"Structural":{"adopted":4.615384615384615,"partial":1.5172413793103448,"not adopted":1.7647058823529411,"null":2.717948717948718},"Health systems":{"adopted":3.4473684210526314,"partial":1.6923076923076923,"not adopted":1.411764705882353,"null":3.2}},"policyAreaScores":{"Structural":71.0454822954823,"Overall":74.65773809523809,"Clinical and treatment":77.63392857142856,"Testing and prevention":67.57109788359789,"Health systems":83.75160875160873}},"2021":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.4761904761904763,"partial":1.1875,"not adopted":1.7142857142857142,"null":5.935483870967742},"Overall":{"adopted":3.7480916030534353,"partial":1.3142857142857143,"not adopted":2.048076923076923,"null":3.637037037037037},"Testing and prevention":{"adopted":3.272727272727273,"partial":1.1428571428571428,"not adopted":1.7692307692307692,"null":4.303030303030303},"Structural":{"adopted":4.615384615384615,"partial":1.2962962962962963,"not adopted":2.7435897435897436,"null":1.7435897435897436},"Health systems":{"adopted":3.4210526315789473,"partial":1.6923076923076923,"not adopted":1.3333333333333333,"null":3.03125}},"policyAreaScores":{"Structural":61.21286121286123,"Overall":72.05750547345377,"Clinical and treatment":70.01587301587301,"Testing and prevention":72.26419413919415,"Health systems":84.50727513227513}},"2022":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.4545454545454546,"partial":1.1764705882352942,"not adopted":1.7391304347826086,"null":5.67741935483871},"Overall":{"adopted":3.8455882352941178,"partial":1.273972602739726,"not adopted":2.150943396226415,"null":3.330827067669173},"Testing and prevention":{"adopted":3.4594594594594597,"partial":1.2,"not adopted":2.0384615384615383,"null":3.53125},"Structural":{"adopted":4.794871794871795,"partial":1.1785714285714286,"not adopted":2.7948717948717947,"null":1.564102564102564},"Health systems":{"adopted":3.473684210526316,"partial":1.6923076923076923,"not adopted":1.4444444444444444,"null":3}},"policyAreaScores":{"Structural":61.8945868945869,"Overall":71.70757020757026,"Clinical and treatment":68.74649859943978,"Testing and prevention":71.62162162162163,"Health systems":83.49742599742599}},"2023":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.4545454545454546,"partial":1.1764705882352942,"not adopted":1.7391304347826086,"null":5.67741935483871},"Overall":{"adopted":3.8529411764705883,"partial":1.2777777777777777,"not adopted":2.150943396226415,"null":3.330827067669173},"Testing and prevention":{"adopted":3.4864864864864864,"partial":1.2142857142857142,"not adopted":2.0384615384615383,"null":3.53125},"Structural":{"adopted":4.794871794871795,"partial":1.1785714285714286,"not adopted":2.7948717948717947,"null":1.564102564102564},"Health systems":{"adopted":3.473684210526316,"partial":1.6923076923076923,"not adopted":1.4444444444444444,"null":3}},"policyAreaScores":{"Structural":61.876780626780636,"Overall":71.75717338217342,"Clinical and treatment":68.74649859943978,"Testing and prevention":71.81467181467181,"Health systems":83.49742599742599}},"2024":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.4545454545454546,"partial":1.1764705882352942,"not adopted":1.7391304347826086,"null":5.67741935483871},"Overall":{"adopted":3.8455882352941178,"partial":1.273972602739726,"not adopted":2.150943396226415,"null":3.330827067669173},"Testing and prevention":{"adopted":3.4594594594594597,"partial":1.2,"not adopted":2.0384615384615383,"null":3.53125},"Structural":{"adopted":4.794871794871795,"partial":1.1785714285714286,"not adopted":2.7948717948717947,"null":1.564102564102564},"Health systems":{"adopted":3.473684210526316,"partial":1.6923076923076923,"not adopted":1.4444444444444444,"null":3}},"policyAreaScores":{"Structural":61.876780626780636,"Overall":71.7090964590965,"Clinical and treatment":68.74649859943978,"Testing and prevention":71.64575289575289,"Health systems":83.49742599742599}},"recent":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.3684210526315788,"partial":1.5,"not adopted":2.0714285714285716,"null":3.5555555555555554},"Overall":{"adopted":3.849673202614379,"partial":1.608695652173913,"not adopted":2.237704918032787,"null":2.4298245614035086},"Testing and prevention":{"adopted":3.7837837837837838,"partial":1.3703703703703705,"not adopted":2.3870967741935485,"null":2.9047619047619047},"Structural":{"adopted":4.794871794871795,"partial":1.8333333333333333,"not adopted":2.7948717948717947,"null":1.0833333333333333},"Health systems":{"adopted":3.4358974358974357,"partial":1.7333333333333334,"not adopted":1.3333333333333333,"null":2.7}},"policyAreaScores":{"Clinical and treatment":66.98359073359075,"Overall":67.66162093976665,"Testing and prevention":63.9591377091377,"Structural":61.034798534798554,"Health systems":78.72807017543857}}},"Eastern and southern Africa":{"2017":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.75,"partial":1.3157894736842106,"not adopted":1.4444444444444444,"null":1.75},"Overall":{"adopted":3.0123456790123457,"partial":1.53125,"not adopted":3.0163934426229506,"null":2.0875},"Testing and prevention":{"adopted":2.5,"partial":1.5555555555555556,"not adopted":3.3157894736842106,"null":1.5},"Structural":{"adopted":2.65,"partial":1.9,"not adopted":4.238095238095238,"null":1.4285714285714286},"Health systems":{"adopted":2.1904761904761907,"partial":1,"not adopted":1.5833333333333333,"null":3.5714285714285716}},"policyAreaScores":{"Clinical and treatment":80.35416666666669,"Overall":58.308103076621606,"Testing and prevention":44.65178571428571,"Structural":39.65891912320484,"Health systems":69.49999999999999}},"2018":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.666666666666667,"partial":1.15,"not adopted":1.2222222222222223,"null":2.1176470588235294},"Overall":{"adopted":3.4819277108433737,"partial":1.4444444444444444,"not adopted":2.8412698412698414,"null":2.392857142857143},"Testing and prevention":{"adopted":3.619047619047619,"partial":1.2666666666666666,"not adopted":2.75,"null":2},"Structural":{"adopted":3.25,"partial":2.05,"not adopted":4.476190476190476,"null":1.1111111111111112},"Health systems":{"adopted":2.380952380952381,"partial":1,"not adopted":1.4615384615384615,"null":3.3333333333333335}},"policyAreaScores":{"Clinical and treatment":82.23511904761907,"Overall":62.76543747580334,"Testing and prevention":55.56122448979592,"Structural":42.632275132275126,"Health systems":72}},"2019":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":5.190476190476191,"partial":1.1666666666666667,"not adopted":1.5714285714285714,"null":1.588235294117647},"Overall":{"adopted":3.8536585365853657,"partial":1.4615384615384615,"not adopted":2.707692307692308,"null":1.6825396825396826},"Testing and prevention":{"adopted":4.25,"partial":1.1578947368421053,"not adopted":2.5,"null":2.2},"Structural":{"adopted":3.1,"partial":2.263157894736842,"not adopted":4.0476190476190474,"null":1},"Health systems":{"adopted":2.857142857142857,"partial":1,"not adopted":1.7647058823529411,"null":2.2857142857142856}},"policyAreaScores":{"Clinical and treatment":84.4791666666667,"Overall":63.67798353909464,"Testing and prevention":61.66666666666665,"Structural":43.96825396825396,"Health systems":65.58333333333333}},"2020":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":6.095238095238095,"partial":1.4285714285714286,"not adopted":1.1666666666666667,"null":1.8571428571428572},"Overall":{"adopted":4.27710843373494,"partial":1.8032786885245902,"not adopted":2.3220338983050848,"null":1.8958333333333333},"Testing and prevention":{"adopted":4.095238095238095,"partial":1.4166666666666667,"not adopted":2.5,"null":1.6666666666666667},"Structural":{"adopted":3.3,"partial":1.9444444444444444,"not adopted":3.0476190476190474,"null":2.142857142857143},"Health systems":{"adopted":3.5714285714285716,"partial":2.235294117647059,"not adopted":1.5,"null":1.625}},"policyAreaScores":{"Clinical and treatment":88.6904761904762,"Overall":68.015873015873,"Testing and prevention":63.71428571428571,"Structural":50.45351473922903,"Health systems":70.08333333333334}},"2021":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":5.476190476190476,"partial":1.2857142857142858,"not adopted":1.7142857142857142,"null":3.8333333333333335},"Overall":{"adopted":4.120481927710843,"partial":1.5666666666666667,"not adopted":2.7857142857142856,"null":2.1041666666666665},"Testing and prevention":{"adopted":4.0476190476190474,"partial":1.2727272727272727,"not adopted":2.6470588235294117,"null":2.6666666666666665},"Structural":{"adopted":3.5,"partial":2,"not adopted":3.9047619047619047,"null":1.1578947368421053},"Health systems":{"adopted":3.4285714285714284,"partial":1.5294117647058822,"not adopted":1.5454545454545454,"null":2.2857142857142856}},"policyAreaScores":{"Clinical and treatment":85.83959899749375,"Overall":66.92311507936506,"Testing and prevention":63.34821428571429,"Structural":46.699735449735456,"Health systems":73.76190476190476}},"2022":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":5.904761904761905,"partial":1.3571428571428572,"not adopted":1.6666666666666667,"null":3},"Overall":{"adopted":4.397590361445783,"partial":1.6,"not adopted":2.6666666666666665,"null":1.6744186046511629},"Testing and prevention":{"adopted":4.428571428571429,"partial":1.375,"not adopted":2.3157894736842106,"null":1.8},"Structural":{"adopted":3.6,"partial":2.0555555555555554,"not adopted":3.8095238095238093,"null":1.105263157894737},"Health systems":{"adopted":3.619047619047619,"partial":1.5294117647058822,"not adopted":1.6363636363636365,"null":1.9285714285714286}},"policyAreaScores":{"Clinical and treatment":87.58928571428572,"Overall":68.57860011474469,"Testing and prevention":64.8639455782313,"Structural":47.77777777777777,"Health systems":74.98866213151926}},"2023":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":5.904761904761905,"partial":1.3571428571428572,"not adopted":1.6666666666666667,"null":3},"Overall":{"adopted":4.409638554216867,"partial":1.609375,"not adopted":2.6666666666666665,"null":1.6744186046511629},"Testing and prevention":{"adopted":4.428571428571429,"partial":1.375,"not adopted":2.3157894736842106,"null":1.8},"Structural":{"adopted":3.65,"partial":2.1176470588235294,"not adopted":3.8095238095238093,"null":1.105263157894737},"Health systems":{"adopted":3.619047619047619,"partial":1.5294117647058822,"not adopted":1.6363636363636365,"null":1.9285714285714286}},"policyAreaScores":{"Clinical and treatment":87.58928571428572,"Overall":68.65390131956396,"Testing and prevention":64.8639455782313,"Structural":48.07539682539682,"Health systems":74.98866213151926}},"2024":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":5.904761904761905,"partial":1.3571428571428572,"not adopted":1.6666666666666667,"null":3},"Overall":{"adopted":4.421686746987952,"partial":1.59375,"not adopted":2.6666666666666665,"null":1.6744186046511629},"Testing and prevention":{"adopted":4.428571428571429,"partial":1.375,"not adopted":2.3157894736842106,"null":1.8},"Structural":{"adopted":3.7,"partial":2.0588235294117645,"not adopted":3.8095238095238093,"null":1.105263157894737},"Health systems":{"adopted":3.619047619047619,"partial":1.5294117647058822,"not adopted":1.6363636363636365,"null":1.9285714285714286}},"policyAreaScores":{"Clinical and treatment":87.58928571428572,"Overall":68.72083572384777,"Testing and prevention":64.8639455782313,"Structural":48.33994708994709,"Health systems":74.98866213151926}},"recent":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":6.142857142857143,"partial":1.375,"not adopted":1.625,"null":1.3333333333333333},"Overall":{"adopted":4.542168674698795,"partial":1.9295774647887325,"not adopted":2.7719298245614037,"null":1.3125},"Testing and prevention":{"adopted":4.476190476190476,"partial":1.5555555555555556,"not adopted":2.5,"null":1},"Structural":{"adopted":4,"partial":2.2222222222222223,"not adopted":4,"null":1},"Health systems":{"adopted":3.5238095238095237,"partial":2.473684210526316,"not adopted":1.6,"null":1.6666666666666667}},"policyAreaScores":{"Clinical and treatment":85.11904761904762,"Overall":67.4482709750567,"Testing and prevention":64.75340136054422,"Structural":49.04761904761905,"Health systems":70.87301587301589}}},"Latin America and the Caribbean":{"2017":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2.9375,"partial":1.6521739130434783,"not adopted":1.9545454545454546,"null":2.78125},"Overall":{"adopted":2.6260162601626016,"partial":1.5180722891566265,"not adopted":2.6371681415929205,"null":2.9482758620689653},"Testing and prevention":{"adopted":1.9259259259259258,"partial":1.125,"not adopted":4.0625,"null":3.0555555555555554},"Structural":{"adopted":3.909090909090909,"partial":1.8333333333333333,"not adopted":2.962962962962963,"null":2},"Health systems":{"adopted":1.5483870967741935,"partial":1,"not adopted":1.40625,"null":4}},"policyAreaScores":{"Clinical and treatment":63.80070546737215,"Overall":51.43586351919686,"Testing and prevention":30.77996715927751,"Structural":59.502765752765754,"Health systems":51.39880952380953}},"2018":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":2.71875,"partial":1.0454545454545454,"not adopted":1.6,"null":3.4545454545454546},"Overall":{"adopted":2.8548387096774195,"partial":1.3375,"not adopted":2.7203389830508473,"null":2.8962264150943398},"Testing and prevention":{"adopted":2.103448275862069,"partial":1.2,"not adopted":3.9375,"null":2.409090909090909},"Structural":{"adopted":4.333333333333333,"partial":1.6875,"not adopted":3.6333333333333333,"null":1.3333333333333333},"Health systems":{"adopted":2.1,"partial":1,"not adopted":1.4838709677419355,"null":3.515151515151515}},"policyAreaScores":{"Clinical and treatment":63.34183673469387,"Overall":53.087568360677594,"Testing and prevention":34.57341269841269,"Structural":56.13576238576239,"Health systems":59.077380952380956}},"2019":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.5757575757575757,"partial":1.0434782608695652,"not adopted":1.903225806451613,"null":2.032258064516129},"Overall":{"adopted":3.1904761904761907,"partial":1.5057471264367817,"not adopted":2.5196850393700787,"null":2.2476190476190476},"Testing and prevention":{"adopted":2.4838709677419355,"partial":1.4074074074074074,"not adopted":3.5757575757575757,"null":3.875},"Structural":{"adopted":4.242424242424242,"partial":2.032258064516129,"not adopted":3.033333333333333,"null":1.0909090909090908},"Health systems":{"adopted":2.310344827586207,"partial":1,"not adopted":1.5757575757575757,"null":3.212121212121212}},"policyAreaScores":{"Clinical and treatment":63.338913690476204,"Overall":54.82942908346133,"Testing and prevention":41.09062980030722,"Structural":58.228114478114485,"Health systems":56.3095238095238}},"2020":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.606060606060606,"partial":1.4166666666666667,"not adopted":1.7826086956521738,"null":3.5},"Overall":{"adopted":3.28,"partial":1.5212765957446808,"not adopted":2.0530973451327434,"null":3.00990099009901},"Testing and prevention":{"adopted":2.2758620689655173,"partial":1.4,"not adopted":2.75,"null":3.1538461538461537},"Structural":{"adopted":4.242424242424242,"partial":1.5862068965517242,"not adopted":2,"null":2.727272727272727},"Health systems":{"adopted":2.8333333333333335,"partial":1.6666666666666667,"not adopted":1.5806451612903225,"null":2.8181818181818183}},"policyAreaScores":{"Clinical and treatment":70.00661375661376,"Overall":60.936302681992316,"Testing and prevention":43.75821018062397,"Structural":67.43626743626744,"Health systems":62.3721340388007}},"2021":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.793103448275862,"partial":1.6,"not adopted":1.736842105263158,"null":5.235294117647059},"Overall":{"adopted":3.4786324786324787,"partial":1.6091954022988506,"not adopted":2.3944954128440368,"null":3.0543478260869565},"Testing and prevention":{"adopted":3,"partial":1.4444444444444444,"not adopted":2.8125,"null":4.055555555555555},"Structural":{"adopted":4.242424242424242,"partial":1.8666666666666667,"not adopted":3,"null":1.4193548387096775},"Health systems":{"adopted":2.7333333333333334,"partial":1.368421052631579,"not adopted":1.7142857142857142,"null":2.8846153846153846}},"policyAreaScores":{"Structural":58.5906685906686,"Overall":59.12492512728364,"Clinical and treatment":70.11634199134198,"Testing and prevention":47.26666666666667,"Health systems":61.90476190476191}},"2022":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.066666666666666,"partial":1.6521739130434783,"not adopted":2,"null":4.4},"Overall":{"adopted":3.540983606557377,"partial":1.68,"not adopted":2.5,"null":2.5180722891566263},"Testing and prevention":{"adopted":3,"partial":1.4230769230769231,"not adopted":3.090909090909091,"null":2.933333333333333},"Structural":{"adopted":4.242424242424242,"partial":2.03125,"not adopted":2.933333333333333,"null":1.1935483870967742},"Health systems":{"adopted":2.78125,"partial":1.4736842105263157,"not adopted":1.7333333333333334,"null":2.8181818181818183}},"policyAreaScores":{"Testing and prevention":41.88058035714286,"Overall":57.31419827818133,"Structural":58.8973063973064,"Clinical and treatment":70.42857142857142,"Health systems":61.37755102040817}},"2023":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.066666666666666,"partial":1.6521739130434783,"not adopted":2,"null":4.4},"Overall":{"adopted":3.5203252032520327,"partial":1.6868686868686869,"not adopted":2.4910714285714284,"null":2.5},"Testing and prevention":{"adopted":2.9642857142857144,"partial":1.44,"not adopted":3.0606060606060606,"null":2.933333333333333},"Structural":{"adopted":4.212121212121212,"partial":2.03125,"not adopted":2.933333333333333,"null":1.1875},"Health systems":{"adopted":2.78125,"partial":1.4736842105263157,"not adopted":1.7333333333333334,"null":2.8181818181818183}},"policyAreaScores":{"Testing and prevention":42.819940476190474,"Overall":57.54069141781007,"Structural":58.796296296296305,"Clinical and treatment":70.42857142857142,"Health systems":61.37755102040817}},"2024":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.066666666666666,"partial":1.6521739130434783,"not adopted":2,"null":4.4},"Overall":{"adopted":3.5284552845528454,"partial":1.6938775510204083,"not adopted":2.4910714285714284,"null":2.5},"Testing and prevention":{"adopted":2.9642857142857144,"partial":1.44,"not adopted":3.0606060606060606,"null":2.933333333333333},"Structural":{"adopted":4.242424242424242,"partial":2.064516129032258,"not adopted":2.933333333333333,"null":1.1875},"Health systems":{"adopted":2.78125,"partial":1.4736842105263157,"not adopted":1.7333333333333334,"null":2.8181818181818183}},"policyAreaScores":{"Testing and prevention":42.819940476190474,"Overall":57.58777239709443,"Structural":58.96464646464647,"Clinical and treatment":70.42857142857142,"Health systems":61.37755102040817}},"recent":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.575757575757576,"partial":1.6896551724137931,"not adopted":1.76,"null":2.2222222222222223},"Overall":{"adopted":3.7099236641221376,"partial":1.8547008547008548,"not adopted":2.558333333333333,"null":1.880952380952381},"Testing and prevention":{"adopted":3.21875,"partial":1.5666666666666667,"not adopted":3.272727272727273,"null":6},"Structural":{"adopted":4.212121212121212,"partial":2.3333333333333335,"not adopted":3.2580645161290325,"null":1},"Health systems":{"adopted":2.8181818181818183,"partial":1.76,"not adopted":1.7419354838709677,"null":2.1052631578947367}},"policyAreaScores":{"Clinical and treatment":71.22655122655122,"Overall":59.18543956043956,"Testing and prevention":49.4140625,"Structural":56.41414141414142,"Health systems":59.397321428571416}}},"Western and central Africa":{"2017":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.0588235294117645,"partial":1.2,"not adopted":1.608695652173913,"null":3.4166666666666665},"Overall":{"adopted":2.4523809523809526,"partial":1.4736842105263157,"not adopted":2.6818181818181817,"null":3.1145833333333335},"Testing and prevention":{"adopted":2.3333333333333335,"partial":1.6153846153846154,"not adopted":3,"null":2.8181818181818183},"Structural":{"adopted":2.2,"partial":1.6818181818181819,"not adopted":4.24,"null":2.08},"Health systems":{"adopted":1.6666666666666667,"partial":1.1666666666666667,"not adopted":1.2,"null":4.12}},"policyAreaScores":{"Clinical and treatment":69.91246498599442,"Overall":51.28373015873016,"Testing and prevention":38.63095238095237,"Structural":37.16269841269842,"Health systems":67.3611111111111}},"2018":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":3.3,"partial":1,"not adopted":1.5555555555555556,"null":3.875},"Overall":{"adopted":2.7529411764705882,"partial":1.3870967741935485,"not adopted":3.189873417721519,"null":3.2857142857142856},"Testing and prevention":{"adopted":3.0555555555555554,"partial":1.2727272727272727,"not adopted":3.4583333333333335,"null":3},"Structural":{"adopted":2.782608695652174,"partial":1.8695652173913044,"not adopted":5.04,"null":1.4166666666666667},"Health systems":{"adopted":2.0416666666666665,"partial":1.0666666666666667,"not adopted":1.25,"null":3.8}},"policyAreaScores":{"Clinical and treatment":69.08399470899472,"Overall":50.97389558232933,"Testing and prevention":38.276397515527954,"Structural":36.445238095238096,"Health systems":70.34313725490196}},"2019":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.24,"partial":1,"not adopted":1.8666666666666667,"null":2},"Overall":{"adopted":3.1752577319587627,"partial":1.5555555555555556,"not adopted":3,"null":2.0240963855421685},"Testing and prevention":{"adopted":3.217391304347826,"partial":1.3333333333333333,"not adopted":3.4583333333333335,"null":2.5555555555555554},"Structural":{"adopted":2.7083333333333335,"partial":2.3333333333333335,"not adopted":4.16,"null":1},"Health systems":{"adopted":2.52,"partial":1.2,"not adopted":1.4666666666666666,"null":2.88}},"policyAreaScores":{"Clinical and treatment":75.33482142857144,"Overall":58.092731829573914,"Testing and prevention":47.011408730158735,"Structural":41.333333333333314,"Health systems":70.41666666666667}},"2020":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":4.954545454545454,"partial":1.4444444444444444,"not adopted":1.4666666666666666,"null":2.8666666666666667},"Overall":{"adopted":3.510869565217391,"partial":1.6849315068493151,"not adopted":2.0823529411764707,"null":2.8055555555555554},"Testing and prevention":{"adopted":3.65,"partial":1.4615384615384615,"not adopted":2.4583333333333335,"null":2.7222222222222223},"Structural":{"adopted":2.6,"partial":1.9130434782608696,"not adopted":2.5833333333333335,"null":3.2916666666666665},"Health systems":{"adopted":3.04,"partial":1.7894736842105263,"not adopted":1.5454545454545454,"null":2.066666666666667}},"policyAreaScores":{"Clinical and treatment":80.34297052154196,"Overall":61.40574330090461,"Testing and prevention":53.77435064935064,"Structural":50.486507936507934,"Health systems":63.13333333333333}},"2021":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":5.363636363636363,"partial":1.4210526315789473,"not adopted":1.5,"null":3.5833333333333335},"Overall":{"adopted":3.8085106382978724,"partial":1.7352941176470589,"not adopted":2.5135135135135136,"null":2.5076923076923077},"Testing and prevention":{"adopted":3.6956521739130435,"partial":1.5454545454545454,"not adopted":2.4545454545454546,"null":4},"Structural":{"adopted":3.04,"partial":2.25,"not adopted":3.6,"null":1.4285714285714286},"Health systems":{"adopted":3.2916666666666665,"partial":1.4285714285714286,"not adopted":1.5789473684210527,"null":2.1904761904761907}},"policyAreaScores":{"Clinical and treatment":83.29081632653062,"Overall":64.6300563236047,"Testing and prevention":61.13095238095237,"Structural":46.83333333333332,"Health systems":70.1934523809524}},"2022":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":5.434782608695652,"partial":1.5,"not adopted":1.1428571428571428,"null":3.7},"Overall":{"adopted":4,"partial":1.7123287671232876,"not adopted":2.4342105263157894,"null":2.25},"Testing and prevention":{"adopted":4.217391304347826,"partial":1.2,"not adopted":2.3333333333333335,"null":3.2222222222222223},"Structural":{"adopted":3.16,"partial":2.28,"not adopted":3.52,"null":1.2380952380952381},"Health systems":{"adopted":3.2916666666666665,"partial":1.5384615384615385,"not adopted":1.65,"null":2.15}},"policyAreaScores":{"Clinical and treatment":86.23866213151928,"Overall":64.92253461668355,"Testing and prevention":59.83382936507936,"Structural":47.86111111111112,"Health systems":69.13194444444444}},"2023":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":5.434782608695652,"partial":1.5,"not adopted":1.1428571428571428,"null":3.7},"Overall":{"adopted":3.9894736842105263,"partial":1.726027397260274,"not adopted":2.4342105263157894,"null":2.25},"Testing and prevention":{"adopted":4.173913043478261,"partial":1.3333333333333333,"not adopted":2.2916666666666665,"null":3.2222222222222223},"Structural":{"adopted":3.16,"partial":2.24,"not adopted":3.56,"null":1.2380952380952381},"Health systems":{"adopted":3.2916666666666665,"partial":1.5384615384615385,"not adopted":1.65,"null":2.15}},"policyAreaScores":{"Clinical and treatment":86.23866213151928,"Overall":64.99493414387031,"Testing and prevention":60.35466269841269,"Structural":47.63333333333335,"Health systems":69.13194444444444}},"2024":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":5.434782608695652,"partial":1.5,"not adopted":1.1428571428571428,"null":3.7},"Overall":{"adopted":3.9894736842105263,"partial":1.726027397260274,"not adopted":2.4342105263157894,"null":2.25},"Testing and prevention":{"adopted":4.173913043478261,"partial":1.3333333333333333,"not adopted":2.2916666666666665,"null":3.2222222222222223},"Structural":{"adopted":3.16,"partial":2.24,"not adopted":3.56,"null":1.2380952380952381},"Health systems":{"adopted":3.2916666666666665,"partial":1.5384615384615385,"not adopted":1.65,"null":2.15}},"policyAreaScores":{"Clinical and treatment":86.23866213151928,"Overall":64.99493414387031,"Testing and prevention":60.35466269841269,"Structural":47.63333333333335,"Health systems":69.13194444444444}},"recent":{"policyAreaAdoption":{"Clinical and treatment":{"adopted":5.48,"partial":1.5217391304347827,"not adopted":1.6666666666666667,"null":1.3333333333333333},"Overall":{"adopted":4.0606060606060606,"partial":1.9540229885057472,"not adopted":2.6049382716049383,"null":1.5},"Testing and prevention":{"adopted":4.25,"partial":1.5,"not adopted":2.6666666666666665,"null":2.3333333333333335},"Structural":{"adopted":3.16,"partial":2.76,"not adopted":3.84,"null":1},"Health systems":{"adopted":3.36,"partial":1.8571428571428572,"not adopted":1.55,"null":1.6153846153846154}},"policyAreaScores":{"Clinical and treatment":79.93571428571428,"Overall":63.0345238095238,"Testing and prevention":58.10714285714286,"Structural":46.46666666666667,"Health systems":67.62857142857142}}}},"subScores":{"2015":{},"2016":{},"2017":{"CT1":{"value":1,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":"adopted","parentCode":"CT1","year":"2017","id":42360,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"parentCode":"CT2","year":"2017","id":42361,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":1,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":"adopted","parentCode":"CT3","year":"2017","id":42363,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4i":{"value":0,"code":"CT4i","title":"Community ART distribution","descrip":"Does national policy allow for community ART distribution?","level":"not adopted","parentCode":"CT4","year":"2017","id":42366,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4ii":{"value":0.5,"code":"CT4ii","title":"Clinic visit frequency","descrip":"Does national policy allow for reduced frequency of clinical visits?","level":"partial","parentCode":"CT4","year":"2017","id":42370,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4iii":{"value":0.5,"code":"CT4iii","title":"Multi-month dispensing","descrip":"Does national policy allow for multi-month dispensing?","level":"partial","parentCode":"CT4","year":"2017","id":42375,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":1,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":"adopted","parentCode":"CT5","year":"2017","id":42381,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6i":{"value":1,"code":"CT6i","title":"Peds- Diagnosis","descrip":"Does early infant diagnosis policy align with WHO recommendations on the use of point-of-care tests?","level":"adopted","parentCode":"CT6","year":"2017","id":54322,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6ii":{"value":1,"code":"CT6ii","title":"Peds- Treatment","descrip":"Does the first-line ARV regimen for infants and children included in national guidelines align with WHO recommendations?","level":"adopted","parentCode":"CT6","year":"2017","id":54330,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7i":{"value":null,"code":"CT7i","title":"Migrants-Primary health care","descrip":"Is primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":null,"parentCode":"CT7","year":"2017","id":42405,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7ii":{"value":null,"code":"CT7ii","title":"Migrants-HIV services","descrip":"Are HIV services available to all migrants under the same conditions as citizens under national policy?","level":null,"parentCode":"CT7","year":"2017","id":42415,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":0,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":"not adopted","parentCode":"CT8","year":"2017","id":42426,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","parentCode":"TP1","year":"2017","id":42438,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2i":{"value":1,"code":"TP2i","title":"Index testing ","descrip":"Is index testing/partner notification provided for in national guidelines?","level":"adopted","parentCode":"TP2","year":"2017","id":42451,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2ii":{"value":null,"code":"TP2ii","title":"Confidentiality in index testing","descrip":"Do partner notification guidelines include confidentiality and robust  protections against disclosure of HIV status without patients consent?","level":null,"parentCode":"TP2","year":"2017","id":42465,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":1,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":"adopted","parentCode":"TP3","year":"2017","id":42480,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":0,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":"not adopted","parentCode":"TP4","year":"2017","id":42496,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5i":{"value":0,"code":"TP5i","title":"PrEP-Policy","descrip":"Are people/populations at substantial risk of HIV infection identified and eligible for PrEP under national policy?","level":"not adopted","parentCode":"TP5","year":"2017","id":42513,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5ii":{"value":1,"code":"TP5ii","title":"PrEP-Regulatory approval","descrip":"Has at least one form of PrEP received national regulatory approval?","level":"adopted","parentCode":"TP5","year":"2017","id":42531,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6i":{"value":1,"code":"TP6i","title":"Harm reduction strategy","descrip":"Is harm reduction included in national policy & service packages for people who inject drugs?","level":"adopted","parentCode":"TP6","year":"2017","id":42550,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6ii":{"value":1,"code":"TP6ii","title":"Syringe non-criminalization","descrip":"Does national law avoid imposing criminal penalties for possession of syringes and associated paraphernalia?","level":"adopted","parentCode":"TP6","year":"2017","id":54504,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":0,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":"not adopted","parentCode":"TP7","year":"2017","id":42591,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8i":{"value":0,"code":"TP8i","title":"Prisons- Condoms","descrip":"Are condoms/lubricant available in prisons as a matter of national policy?","level":"not adopted","parentCode":"TP8","year":"2017","id":42613,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8ii":{"value":0,"code":"TP8ii","title":"Prisons- Needle & syringe programs","descrip":"Are syringe access/exchange programs available in prisons as a matter of national policy?","level":"not adopted","parentCode":"TP8","year":"2017","id":42636,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1i":{"value":0,"code":"S1i","title":"Same-sex sex non-criminalization- Laws","descrip":"Does national law refrain from criminalizing consensual same-sex sexual acts?","level":"not adopted","parentCode":"S1","year":"2017","id":42660,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1ii":{"value":1,"code":"S1ii","title":"Same-sex sex non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided prosecution for consensual same-sex acts in recent years?","level":"adopted","parentCode":"S1","year":"2017","id":42685,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","parentCode":"S2","year":"2017","id":42711,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","parentCode":"S3","year":"2017","id":42738,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4i":{"value":1,"code":"S4i","title":"HIV exposure non-criminalization- Laws","descrip":"Does national law refrain from criminalizing HIV exposure/transmission?","level":"adopted","parentCode":"S4","year":"2017","id":42766,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4ii":{"value":1,"code":"S4ii","title":"HIV exposure non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided arrests/prosecution for HIV transmission/exposure in recent years?","level":"adopted","parentCode":"S4","year":"2017","id":42795,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5i":{"value":0,"code":"S5i","title":"Non-discrimination- Sexual orientation","descrip":"Do national laws protect people from discrimination on the basis of sexual orientation?","level":"not adopted","parentCode":"S5","year":"2017","id":42825,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5ii":{"value":0,"code":"S5ii","title":"Non-discrimination- Gender identity","descrip":"Do national laws protect people from discrimination on the basis of gender identity/diversity?","level":"not adopted","parentCode":"S5","year":"2017","id":54790,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5iii":{"value":null,"code":"S5iii","title":"Non-discrimination- HIV status","descrip":"Do national laws protect people from discrimination on the basis of HIV status?","level":null,"parentCode":"S5","year":"2017","id":42888,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","parentCode":"S6","year":"2017","id":42921,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":null,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":null,"parentCode":"S7","year":"2017","id":42955,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"parentCode":"S8","year":"2017","id":42990,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","parentCode":"S9","year":"2017","id":43026,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10i":{"value":1,"code":"S10i","title":"Civil society- Social contracting","descrip":"Does national policy provide for social contracting (or other mechanisms by which the government finances CSOs to provide health services)?","level":"adopted","parentCode":"S10","year":"2017","id":43063,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10ii":{"value":0,"code":"S10ii","title":"Civil society- Freedom","descrip":"Are NGOs/CSOs, including those working with key populations, able to officially register, seek funding, and operate freely under national laws and policies?","level":"not adopted","parentCode":"S10","year":"2017","id":43101,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":0,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":"not adopted","parentCode":"HS1","year":"2017","id":55074,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2i":{"value":1,"code":"HS2i","title":"Health financing- Budget","descrip":"Does the percent of government spending going to health align with the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2017","id":43180,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2ii":{"value":0,"code":"HS2ii","title":"Health financing- Tax revenue","descrip":"Does government collect adequate tax revenue to align with the tax:GDP ratio in the Global Fund co-financing targets?","level":"not adopted","parentCode":"HS2","year":"2017","id":43221,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3i":{"value":null,"code":"HS3i","title":"UHC- ARVs","descrip":"Are ARVs covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2017","id":43263,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3ii":{"value":null,"code":"HS3ii","title":"UHC- PrEP","descrip":"Is PrEP covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2017","id":43306,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4i":{"value":null,"code":"HS4i","title":"User fees- Primary care","descrip":"Are primary healthcare services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2017","id":43350,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4ii":{"value":null,"code":"HS4ii","title":"User fees- HIV services","descrip":"Are HIV services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2017","id":43395,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5i":{"value":null,"code":"HS5i","title":"TRIPS- Incorporation","descrip":"Are TRIPS flexibilities (including parallel importation, compulsory licensing, and LDC extension) incorporated in national law?","level":null,"parentCode":"HS5","year":"2017","id":43441,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5ii":{"value":0,"code":"HS5ii","title":"TRIPS- Use","descrip":"Are there documented examples of the country utilizing TRIPS flexibilities?","level":"not adopted","parentCode":"HS5","year":"2017","id":43488,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6i":{"value":0,"code":"HS6i","title":"Unique IDs- Use","descrip":"Is there a unique ID (or other method of de-duplicating data) that allows for continuity of care across multiple facilities?","level":"not adopted","parentCode":"HS6","year":"2017","id":43536,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6ii":{"value":null,"code":"HS6ii","title":"Data protections","descrip":"Does national law include legally enforceable protections against disclosure of individually-identifiable health data, including HIV status?","level":null,"parentCode":"HS6","year":"2017","id":43585,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7i":{"value":null,"code":"HS7i","title":"Data sharing- Disaggregation","descrip":"Is data disaggregated by geographic region, age, and gender?","level":null,"parentCode":"HS7","year":"2017","id":43635,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7ii":{"value":null,"code":"HS7ii","title":"Data sharing- Frequency","descrip":"Is data shared at least quarterly?","level":null,"parentCode":"HS7","year":"2017","id":43686,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2018":{"CT1":{"value":1,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":"adopted","parentCode":"CT1","year":"2018","id":43686,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"parentCode":"CT2","year":"2018","id":43687,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"parentCode":"CT3","year":"2018","id":43689,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4i":{"value":0,"code":"CT4i","title":"Community ART distribution","descrip":"Does national policy allow for community ART distribution?","level":"not adopted","parentCode":"CT4","year":"2018","id":43692,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4ii":{"value":0.5,"code":"CT4ii","title":"Clinic visit frequency","descrip":"Does national policy allow for reduced frequency of clinical visits?","level":"partial","parentCode":"CT4","year":"2018","id":54304,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4iii":{"value":0.5,"code":"CT4iii","title":"Multi-month dispensing","descrip":"Does national policy allow for multi-month dispensing?","level":"partial","parentCode":"CT4","year":"2018","id":43701,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":1,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":"adopted","parentCode":"CT5","year":"2018","id":54315,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6i":{"value":null,"code":"CT6i","title":"Peds- Diagnosis","descrip":"Does early infant diagnosis policy align with WHO recommendations on the use of point-of-care tests?","level":null,"parentCode":"CT6","year":"2018","id":43714,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6ii":{"value":null,"code":"CT6ii","title":"Peds- Treatment","descrip":"Does the first-line ARV regimen for infants and children included in national guidelines align with WHO recommendations?","level":null,"parentCode":"CT6","year":"2018","id":43722,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7i":{"value":null,"code":"CT7i","title":"Migrants-Primary health care","descrip":"Is primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":null,"parentCode":"CT7","year":"2018","id":43731,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7ii":{"value":null,"code":"CT7ii","title":"Migrants-HIV services","descrip":"Are HIV services available to all migrants under the same conditions as citizens under national policy?","level":null,"parentCode":"CT7","year":"2018","id":43741,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":0,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":"not adopted","parentCode":"CT8","year":"2018","id":43752,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","parentCode":"TP1","year":"2018","id":43764,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2i":{"value":1,"code":"TP2i","title":"Index testing ","descrip":"Is index testing/partner notification provided for in national guidelines?","level":"adopted","parentCode":"TP2","year":"2018","id":43777,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2ii":{"value":null,"code":"TP2ii","title":"Confidentiality in index testing","descrip":"Do partner notification guidelines include confidentiality and robust  protections against disclosure of HIV status without patients consent?","level":null,"parentCode":"TP2","year":"2018","id":43791,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":1,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":"adopted","parentCode":"TP3","year":"2018","id":54414,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":0,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":"not adopted","parentCode":"TP4","year":"2018","id":43822,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5i":{"value":0,"code":"TP5i","title":"PrEP-Policy","descrip":"Are people/populations at substantial risk of HIV infection identified and eligible for PrEP under national policy?","level":"not adopted","parentCode":"TP5","year":"2018","id":43839,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5ii":{"value":1,"code":"TP5ii","title":"PrEP-Regulatory approval","descrip":"Has at least one form of PrEP received national regulatory approval?","level":"adopted","parentCode":"TP5","year":"2018","id":43857,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6i":{"value":0,"code":"TP6i","title":"Harm reduction strategy","descrip":"Is harm reduction included in national policy & service packages for people who inject drugs?","level":"not adopted","parentCode":"TP6","year":"2018","id":43876,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6ii":{"value":null,"code":"TP6ii","title":"Syringe non-criminalization","descrip":"Does national law avoid imposing criminal penalties for possession of syringes and associated paraphernalia?","level":null,"parentCode":"TP6","year":"2018","id":43896,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"parentCode":"TP7","year":"2018","id":43917,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8i":{"value":null,"code":"TP8i","title":"Prisons- Condoms","descrip":"Are condoms/lubricant available in prisons as a matter of national policy?","level":null,"parentCode":"TP8","year":"2018","id":43939,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8ii":{"value":0,"code":"TP8ii","title":"Prisons- Needle & syringe programs","descrip":"Are syringe access/exchange programs available in prisons as a matter of national policy?","level":"not adopted","parentCode":"TP8","year":"2018","id":43962,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1i":{"value":0,"code":"S1i","title":"Same-sex sex non-criminalization- Laws","descrip":"Does national law refrain from criminalizing consensual same-sex sexual acts?","level":"not adopted","parentCode":"S1","year":"2018","id":43986,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1ii":{"value":1,"code":"S1ii","title":"Same-sex sex non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided prosecution for consensual same-sex acts in recent years?","level":"adopted","parentCode":"S1","year":"2018","id":44011,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","parentCode":"S2","year":"2018","id":44037,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","parentCode":"S3","year":"2018","id":44064,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4i":{"value":1,"code":"S4i","title":"HIV exposure non-criminalization- Laws","descrip":"Does national law refrain from criminalizing HIV exposure/transmission?","level":"adopted","parentCode":"S4","year":"2018","id":44092,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4ii":{"value":1,"code":"S4ii","title":"HIV exposure non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided arrests/prosecution for HIV transmission/exposure in recent years?","level":"adopted","parentCode":"S4","year":"2018","id":44121,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5i":{"value":0,"code":"S5i","title":"Non-discrimination- Sexual orientation","descrip":"Do national laws protect people from discrimination on the basis of sexual orientation?","level":"not adopted","parentCode":"S5","year":"2018","id":44151,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5ii":{"value":null,"code":"S5ii","title":"Non-discrimination- Gender identity","descrip":"Do national laws protect people from discrimination on the basis of gender identity/diversity?","level":null,"parentCode":"S5","year":"2018","id":44182,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5iii":{"value":null,"code":"S5iii","title":"Non-discrimination- HIV status","descrip":"Do national laws protect people from discrimination on the basis of HIV status?","level":null,"parentCode":"S5","year":"2018","id":44214,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","parentCode":"S6","year":"2018","id":44247,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","parentCode":"S7","year":"2018","id":44281,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"parentCode":"S8","year":"2018","id":44316,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","parentCode":"S9","year":"2018","id":44352,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10i":{"value":1,"code":"S10i","title":"Civil society- Social contracting","descrip":"Does national policy provide for social contracting (or other mechanisms by which the government finances CSOs to provide health services)?","level":"adopted","parentCode":"S10","year":"2018","id":54997,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10ii":{"value":0,"code":"S10ii","title":"Civil society- Freedom","descrip":"Are NGOs/CSOs, including those working with key populations, able to officially register, seek funding, and operate freely under national laws and policies?","level":"not adopted","parentCode":"S10","year":"2018","id":44427,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"parentCode":"HS1","year":"2018","id":44466,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2i":{"value":1,"code":"HS2i","title":"Health financing- Budget","descrip":"Does the percent of government spending going to health align with the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2018","id":44506,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2ii":{"value":1,"code":"HS2ii","title":"Health financing- Tax revenue","descrip":"Does government collect adequate tax revenue to align with the tax:GDP ratio in the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2018","id":44547,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3i":{"value":null,"code":"HS3i","title":"UHC- ARVs","descrip":"Are ARVs covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2018","id":44589,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3ii":{"value":null,"code":"HS3ii","title":"UHC- PrEP","descrip":"Is PrEP covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2018","id":44632,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4i":{"value":null,"code":"HS4i","title":"User fees- Primary care","descrip":"Are primary healthcare services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2018","id":44676,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4ii":{"value":null,"code":"HS4ii","title":"User fees- HIV services","descrip":"Are HIV services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2018","id":44721,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5i":{"value":null,"code":"HS5i","title":"TRIPS- Incorporation","descrip":"Are TRIPS flexibilities (including parallel importation, compulsory licensing, and LDC extension) incorporated in national law?","level":null,"parentCode":"HS5","year":"2018","id":44767,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5ii":{"value":0,"code":"HS5ii","title":"TRIPS- Use","descrip":"Are there documented examples of the country utilizing TRIPS flexibilities?","level":"not adopted","parentCode":"HS5","year":"2018","id":44814,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6i":{"value":0,"code":"HS6i","title":"Unique IDs- Use","descrip":"Is there a unique ID (or other method of de-duplicating data) that allows for continuity of care across multiple facilities?","level":"not adopted","parentCode":"HS6","year":"2018","id":44862,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6ii":{"value":null,"code":"HS6ii","title":"Data protections","descrip":"Does national law include legally enforceable protections against disclosure of individually-identifiable health data, including HIV status?","level":null,"parentCode":"HS6","year":"2018","id":44911,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7i":{"value":null,"code":"HS7i","title":"Data sharing- Disaggregation","descrip":"Is data disaggregated by geographic region, age, and gender?","level":null,"parentCode":"HS7","year":"2018","id":44961,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7ii":{"value":null,"code":"HS7ii","title":"Data sharing- Frequency","descrip":"Is data shared at least quarterly?","level":null,"parentCode":"HS7","year":"2018","id":45012,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2019":{"CT1":{"value":1,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":"adopted","parentCode":"CT1","year":"2019","id":45012,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"parentCode":"CT2","year":"2019","id":45013,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":0,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":"not adopted","parentCode":"CT3","year":"2019","id":54297,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4i":{"value":0,"code":"CT4i","title":"Community ART distribution","descrip":"Does national policy allow for community ART distribution?","level":"not adopted","parentCode":"CT4","year":"2019","id":45018,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4ii":{"value":null,"code":"CT4ii","title":"Clinic visit frequency","descrip":"Does national policy allow for reduced frequency of clinical visits?","level":null,"parentCode":"CT4","year":"2019","id":45022,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4iii":{"value":0.5,"code":"CT4iii","title":"Multi-month dispensing","descrip":"Does national policy allow for multi-month dispensing?","level":"partial","parentCode":"CT4","year":"2019","id":45027,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"parentCode":"CT5","year":"2019","id":45033,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6i":{"value":null,"code":"CT6i","title":"Peds- Diagnosis","descrip":"Does early infant diagnosis policy align with WHO recommendations on the use of point-of-care tests?","level":null,"parentCode":"CT6","year":"2019","id":45040,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6ii":{"value":null,"code":"CT6ii","title":"Peds- Treatment","descrip":"Does the first-line ARV regimen for infants and children included in national guidelines align with WHO recommendations?","level":null,"parentCode":"CT6","year":"2019","id":45048,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7i":{"value":null,"code":"CT7i","title":"Migrants-Primary health care","descrip":"Is primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":null,"parentCode":"CT7","year":"2019","id":45057,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7ii":{"value":null,"code":"CT7ii","title":"Migrants-HIV services","descrip":"Are HIV services available to all migrants under the same conditions as citizens under national policy?","level":null,"parentCode":"CT7","year":"2019","id":45067,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":0,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":"not adopted","parentCode":"CT8","year":"2019","id":45078,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","parentCode":"TP1","year":"2019","id":45090,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2i":{"value":1,"code":"TP2i","title":"Index testing ","descrip":"Is index testing/partner notification provided for in national guidelines?","level":"adopted","parentCode":"TP2","year":"2019","id":45103,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2ii":{"value":null,"code":"TP2ii","title":"Confidentiality in index testing","descrip":"Do partner notification guidelines include confidentiality and robust  protections against disclosure of HIV status without patients consent?","level":null,"parentCode":"TP2","year":"2019","id":45117,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"parentCode":"TP3","year":"2019","id":45132,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":0,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":"not adopted","parentCode":"TP4","year":"2019","id":54430,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5i":{"value":0,"code":"TP5i","title":"PrEP-Policy","descrip":"Are people/populations at substantial risk of HIV infection identified and eligible for PrEP under national policy?","level":"not adopted","parentCode":"TP5","year":"2019","id":45165,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5ii":{"value":1,"code":"TP5ii","title":"PrEP-Regulatory approval","descrip":"Has at least one form of PrEP received national regulatory approval?","level":"adopted","parentCode":"TP5","year":"2019","id":45183,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6i":{"value":0,"code":"TP6i","title":"Harm reduction strategy","descrip":"Is harm reduction included in national policy & service packages for people who inject drugs?","level":"not adopted","parentCode":"TP6","year":"2019","id":45202,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6ii":{"value":null,"code":"TP6ii","title":"Syringe non-criminalization","descrip":"Does national law avoid imposing criminal penalties for possession of syringes and associated paraphernalia?","level":null,"parentCode":"TP6","year":"2019","id":45222,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":1,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":"adopted","parentCode":"TP7","year":"2019","id":54525,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8i":{"value":null,"code":"TP8i","title":"Prisons- Condoms","descrip":"Are condoms/lubricant available in prisons as a matter of national policy?","level":null,"parentCode":"TP8","year":"2019","id":45265,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8ii":{"value":0,"code":"TP8ii","title":"Prisons- Needle & syringe programs","descrip":"Are syringe access/exchange programs available in prisons as a matter of national policy?","level":"not adopted","parentCode":"TP8","year":"2019","id":45288,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1i":{"value":0,"code":"S1i","title":"Same-sex sex non-criminalization- Laws","descrip":"Does national law refrain from criminalizing consensual same-sex sexual acts?","level":"not adopted","parentCode":"S1","year":"2019","id":45312,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1ii":{"value":0,"code":"S1ii","title":"Same-sex sex non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided prosecution for consensual same-sex acts in recent years?","level":"not adopted","parentCode":"S1","year":"2019","id":45337,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","parentCode":"S2","year":"2019","id":45363,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","parentCode":"S3","year":"2019","id":45390,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4i":{"value":1,"code":"S4i","title":"HIV exposure non-criminalization- Laws","descrip":"Does national law refrain from criminalizing HIV exposure/transmission?","level":"adopted","parentCode":"S4","year":"2019","id":45418,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4ii":{"value":1,"code":"S4ii","title":"HIV exposure non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided arrests/prosecution for HIV transmission/exposure in recent years?","level":"adopted","parentCode":"S4","year":"2019","id":45447,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5i":{"value":0,"code":"S5i","title":"Non-discrimination- Sexual orientation","descrip":"Do national laws protect people from discrimination on the basis of sexual orientation?","level":"not adopted","parentCode":"S5","year":"2019","id":54759,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5ii":{"value":null,"code":"S5ii","title":"Non-discrimination- Gender identity","descrip":"Do national laws protect people from discrimination on the basis of gender identity/diversity?","level":null,"parentCode":"S5","year":"2019","id":45508,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5iii":{"value":null,"code":"S5iii","title":"Non-discrimination- HIV status","descrip":"Do national laws protect people from discrimination on the basis of HIV status?","level":null,"parentCode":"S5","year":"2019","id":45540,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","parentCode":"S6","year":"2019","id":45573,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","parentCode":"S7","year":"2019","id":45607,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"parentCode":"S8","year":"2019","id":45642,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","parentCode":"S9","year":"2019","id":45678,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10i":{"value":null,"code":"S10i","title":"Civil society- Social contracting","descrip":"Does national policy provide for social contracting (or other mechanisms by which the government finances CSOs to provide health services)?","level":null,"parentCode":"S10","year":"2019","id":45715,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10ii":{"value":0,"code":"S10ii","title":"Civil society- Freedom","descrip":"Are NGOs/CSOs, including those working with key populations, able to officially register, seek funding, and operate freely under national laws and policies?","level":"not adopted","parentCode":"S10","year":"2019","id":45753,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"parentCode":"HS1","year":"2019","id":45792,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2i":{"value":1,"code":"HS2i","title":"Health financing- Budget","descrip":"Does the percent of government spending going to health align with the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2019","id":55114,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2ii":{"value":1,"code":"HS2ii","title":"Health financing- Tax revenue","descrip":"Does government collect adequate tax revenue to align with the tax:GDP ratio in the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2019","id":45873,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3i":{"value":null,"code":"HS3i","title":"UHC- ARVs","descrip":"Are ARVs covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2019","id":45915,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3ii":{"value":null,"code":"HS3ii","title":"UHC- PrEP","descrip":"Is PrEP covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2019","id":45958,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4i":{"value":null,"code":"HS4i","title":"User fees- Primary care","descrip":"Are primary healthcare services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2019","id":46002,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4ii":{"value":null,"code":"HS4ii","title":"User fees- HIV services","descrip":"Are HIV services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2019","id":46047,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5i":{"value":null,"code":"HS5i","title":"TRIPS- Incorporation","descrip":"Are TRIPS flexibilities (including parallel importation, compulsory licensing, and LDC extension) incorporated in national law?","level":null,"parentCode":"HS5","year":"2019","id":46093,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5ii":{"value":0,"code":"HS5ii","title":"TRIPS- Use","descrip":"Are there documented examples of the country utilizing TRIPS flexibilities?","level":"not adopted","parentCode":"HS5","year":"2019","id":46140,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6i":{"value":0,"code":"HS6i","title":"Unique IDs- Use","descrip":"Is there a unique ID (or other method of de-duplicating data) that allows for continuity of care across multiple facilities?","level":"not adopted","parentCode":"HS6","year":"2019","id":46188,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6ii":{"value":null,"code":"HS6ii","title":"Data protections","descrip":"Does national law include legally enforceable protections against disclosure of individually-identifiable health data, including HIV status?","level":null,"parentCode":"HS6","year":"2019","id":46237,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7i":{"value":null,"code":"HS7i","title":"Data sharing- Disaggregation","descrip":"Is data disaggregated by geographic region, age, and gender?","level":null,"parentCode":"HS7","year":"2019","id":46287,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7ii":{"value":null,"code":"HS7ii","title":"Data sharing- Frequency","descrip":"Is data shared at least quarterly?","level":null,"parentCode":"HS7","year":"2019","id":46338,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2020":{"CT1":{"value":1,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":"adopted","parentCode":"CT1","year":"2020","id":54294,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"parentCode":"CT2","year":"2020","id":46339,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"parentCode":"CT3","year":"2020","id":46341,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4i":{"value":0,"code":"CT4i","title":"Community ART distribution","descrip":"Does national policy allow for community ART distribution?","level":"not adopted","parentCode":"CT4","year":"2020","id":54300,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4ii":{"value":null,"code":"CT4ii","title":"Clinic visit frequency","descrip":"Does national policy allow for reduced frequency of clinical visits?","level":null,"parentCode":"CT4","year":"2020","id":46348,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4iii":{"value":0.5,"code":"CT4iii","title":"Multi-month dispensing","descrip":"Does national policy allow for multi-month dispensing?","level":"partial","parentCode":"CT4","year":"2020","id":54309,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"parentCode":"CT5","year":"2020","id":46359,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6i":{"value":null,"code":"CT6i","title":"Peds- Diagnosis","descrip":"Does early infant diagnosis policy align with WHO recommendations on the use of point-of-care tests?","level":null,"parentCode":"CT6","year":"2020","id":46366,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6ii":{"value":null,"code":"CT6ii","title":"Peds- Treatment","descrip":"Does the first-line ARV regimen for infants and children included in national guidelines align with WHO recommendations?","level":null,"parentCode":"CT6","year":"2020","id":46374,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7i":{"value":1,"code":"CT7i","title":"Migrants-Primary health care","descrip":"Is primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2020","id":46383,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7ii":{"value":1,"code":"CT7ii","title":"Migrants-HIV services","descrip":"Are HIV services available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2020","id":46393,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":0,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":"not adopted","parentCode":"CT8","year":"2020","id":54360,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","parentCode":"TP1","year":"2020","id":46416,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2i":{"value":1,"code":"TP2i","title":"Index testing ","descrip":"Is index testing/partner notification provided for in national guidelines?","level":"adopted","parentCode":"TP2","year":"2020","id":54385,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2ii":{"value":null,"code":"TP2ii","title":"Confidentiality in index testing","descrip":"Do partner notification guidelines include confidentiality and robust  protections against disclosure of HIV status without patients consent?","level":null,"parentCode":"TP2","year":"2020","id":46443,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"parentCode":"TP3","year":"2020","id":46458,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":null,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":null,"parentCode":"TP4","year":"2020","id":46474,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5i":{"value":0,"code":"TP5i","title":"PrEP-Policy","descrip":"Are people/populations at substantial risk of HIV infection identified and eligible for PrEP under national policy?","level":"not adopted","parentCode":"TP5","year":"2020","id":46491,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5ii":{"value":1,"code":"TP5ii","title":"PrEP-Regulatory approval","descrip":"Has at least one form of PrEP received national regulatory approval?","level":"adopted","parentCode":"TP5","year":"2020","id":46509,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6i":{"value":0,"code":"TP6i","title":"Harm reduction strategy","descrip":"Is harm reduction included in national policy & service packages for people who inject drugs?","level":"not adopted","parentCode":"TP6","year":"2020","id":46528,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6ii":{"value":null,"code":"TP6ii","title":"Syringe non-criminalization","descrip":"Does national law avoid imposing criminal penalties for possession of syringes and associated paraphernalia?","level":null,"parentCode":"TP6","year":"2020","id":46548,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"parentCode":"TP7","year":"2020","id":46569,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8i":{"value":1,"code":"TP8i","title":"Prisons- Condoms","descrip":"Are condoms/lubricant available in prisons as a matter of national policy?","level":"adopted","parentCode":"TP8","year":"2020","id":46591,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8ii":{"value":0,"code":"TP8ii","title":"Prisons- Needle & syringe programs","descrip":"Are syringe access/exchange programs available in prisons as a matter of national policy?","level":"not adopted","parentCode":"TP8","year":"2020","id":54570,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1i":{"value":0,"code":"S1i","title":"Same-sex sex non-criminalization- Laws","descrip":"Does national law refrain from criminalizing consensual same-sex sexual acts?","level":"not adopted","parentCode":"S1","year":"2020","id":46638,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1ii":{"value":0,"code":"S1ii","title":"Same-sex sex non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided prosecution for consensual same-sex acts in recent years?","level":"not adopted","parentCode":"S1","year":"2020","id":46663,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","parentCode":"S2","year":"2020","id":46689,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":null,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":null,"parentCode":"S3","year":"2020","id":46716,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4i":{"value":1,"code":"S4i","title":"HIV exposure non-criminalization- Laws","descrip":"Does national law refrain from criminalizing HIV exposure/transmission?","level":"adopted","parentCode":"S4","year":"2020","id":46744,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4ii":{"value":1,"code":"S4ii","title":"HIV exposure non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided arrests/prosecution for HIV transmission/exposure in recent years?","level":"adopted","parentCode":"S4","year":"2020","id":46773,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5i":{"value":null,"code":"S5i","title":"Non-discrimination- Sexual orientation","descrip":"Do national laws protect people from discrimination on the basis of sexual orientation?","level":null,"parentCode":"S5","year":"2020","id":46803,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5ii":{"value":null,"code":"S5ii","title":"Non-discrimination- Gender identity","descrip":"Do national laws protect people from discrimination on the basis of gender identity/diversity?","level":null,"parentCode":"S5","year":"2020","id":46834,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5iii":{"value":null,"code":"S5iii","title":"Non-discrimination- HIV status","descrip":"Do national laws protect people from discrimination on the basis of HIV status?","level":null,"parentCode":"S5","year":"2020","id":46866,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","parentCode":"S6","year":"2020","id":46899,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","parentCode":"S7","year":"2020","id":46933,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"parentCode":"S8","year":"2020","id":46968,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","parentCode":"S9","year":"2020","id":47004,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10i":{"value":null,"code":"S10i","title":"Civil society- Social contracting","descrip":"Does national policy provide for social contracting (or other mechanisms by which the government finances CSOs to provide health services)?","level":null,"parentCode":"S10","year":"2020","id":47041,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10ii":{"value":0,"code":"S10ii","title":"Civil society- Freedom","descrip":"Are NGOs/CSOs, including those working with key populations, able to officially register, seek funding, and operate freely under national laws and policies?","level":"not adopted","parentCode":"S10","year":"2020","id":47079,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"parentCode":"HS1","year":"2020","id":47118,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2i":{"value":null,"code":"HS2i","title":"Health financing- Budget","descrip":"Does the percent of government spending going to health align with the Global Fund co-financing targets?","level":null,"parentCode":"HS2","year":"2020","id":47158,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2ii":{"value":1,"code":"HS2ii","title":"Health financing- Tax revenue","descrip":"Does government collect adequate tax revenue to align with the tax:GDP ratio in the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2020","id":47199,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3i":{"value":null,"code":"HS3i","title":"UHC- ARVs","descrip":"Are ARVs covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2020","id":47241,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3ii":{"value":null,"code":"HS3ii","title":"UHC- PrEP","descrip":"Is PrEP covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2020","id":47284,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4i":{"value":null,"code":"HS4i","title":"User fees- Primary care","descrip":"Are primary healthcare services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2020","id":47328,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4ii":{"value":null,"code":"HS4ii","title":"User fees- HIV services","descrip":"Are HIV services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2020","id":47373,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5i":{"value":0,"code":"HS5i","title":"TRIPS- Incorporation","descrip":"Are TRIPS flexibilities (including parallel importation, compulsory licensing, and LDC extension) incorporated in national law?","level":"not adopted","parentCode":"HS5","year":"2020","id":47419,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5ii":{"value":0,"code":"HS5ii","title":"TRIPS- Use","descrip":"Are there documented examples of the country utilizing TRIPS flexibilities?","level":"not adopted","parentCode":"HS5","year":"2020","id":47466,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6i":{"value":0,"code":"HS6i","title":"Unique IDs- Use","descrip":"Is there a unique ID (or other method of de-duplicating data) that allows for continuity of care across multiple facilities?","level":"not adopted","parentCode":"HS6","year":"2020","id":55470,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6ii":{"value":null,"code":"HS6ii","title":"Data protections","descrip":"Does national law include legally enforceable protections against disclosure of individually-identifiable health data, including HIV status?","level":null,"parentCode":"HS6","year":"2020","id":47563,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7i":{"value":null,"code":"HS7i","title":"Data sharing- Disaggregation","descrip":"Is data disaggregated by geographic region, age, and gender?","level":null,"parentCode":"HS7","year":"2020","id":47613,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7ii":{"value":null,"code":"HS7ii","title":"Data sharing- Frequency","descrip":"Is data shared at least quarterly?","level":null,"parentCode":"HS7","year":"2020","id":47664,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2021":{"CT1":{"value":null,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":null,"parentCode":"CT1","year":"2021","id":47664,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"parentCode":"CT2","year":"2021","id":47665,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"parentCode":"CT3","year":"2021","id":47667,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4i":{"value":null,"code":"CT4i","title":"Community ART distribution","descrip":"Does national policy allow for community ART distribution?","level":null,"parentCode":"CT4","year":"2021","id":47670,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4ii":{"value":null,"code":"CT4ii","title":"Clinic visit frequency","descrip":"Does national policy allow for reduced frequency of clinical visits?","level":null,"parentCode":"CT4","year":"2021","id":47674,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4iii":{"value":null,"code":"CT4iii","title":"Multi-month dispensing","descrip":"Does national policy allow for multi-month dispensing?","level":null,"parentCode":"CT4","year":"2021","id":47679,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"parentCode":"CT5","year":"2021","id":47685,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6i":{"value":null,"code":"CT6i","title":"Peds- Diagnosis","descrip":"Does early infant diagnosis policy align with WHO recommendations on the use of point-of-care tests?","level":null,"parentCode":"CT6","year":"2021","id":47692,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6ii":{"value":null,"code":"CT6ii","title":"Peds- Treatment","descrip":"Does the first-line ARV regimen for infants and children included in national guidelines align with WHO recommendations?","level":null,"parentCode":"CT6","year":"2021","id":47700,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7i":{"value":1,"code":"CT7i","title":"Migrants-Primary health care","descrip":"Is primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2021","id":47709,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7ii":{"value":1,"code":"CT7ii","title":"Migrants-HIV services","descrip":"Are HIV services available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2021","id":47719,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":null,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":null,"parentCode":"CT8","year":"2021","id":47730,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","parentCode":"TP1","year":"2021","id":47742,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2i":{"value":null,"code":"TP2i","title":"Index testing ","descrip":"Is index testing/partner notification provided for in national guidelines?","level":null,"parentCode":"TP2","year":"2021","id":47755,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2ii":{"value":null,"code":"TP2ii","title":"Confidentiality in index testing","descrip":"Do partner notification guidelines include confidentiality and robust  protections against disclosure of HIV status without patients consent?","level":null,"parentCode":"TP2","year":"2021","id":47769,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"parentCode":"TP3","year":"2021","id":47784,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":null,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":null,"parentCode":"TP4","year":"2021","id":47800,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5i":{"value":0,"code":"TP5i","title":"PrEP-Policy","descrip":"Are people/populations at substantial risk of HIV infection identified and eligible for PrEP under national policy?","level":"not adopted","parentCode":"TP5","year":"2021","id":47817,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5ii":{"value":1,"code":"TP5ii","title":"PrEP-Regulatory approval","descrip":"Has at least one form of PrEP received national regulatory approval?","level":"adopted","parentCode":"TP5","year":"2021","id":47835,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6i":{"value":null,"code":"TP6i","title":"Harm reduction strategy","descrip":"Is harm reduction included in national policy & service packages for people who inject drugs?","level":null,"parentCode":"TP6","year":"2021","id":47854,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6ii":{"value":null,"code":"TP6ii","title":"Syringe non-criminalization","descrip":"Does national law avoid imposing criminal penalties for possession of syringes and associated paraphernalia?","level":null,"parentCode":"TP6","year":"2021","id":47874,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"parentCode":"TP7","year":"2021","id":47895,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8i":{"value":1,"code":"TP8i","title":"Prisons- Condoms","descrip":"Are condoms/lubricant available in prisons as a matter of national policy?","level":"adopted","parentCode":"TP8","year":"2021","id":47917,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8ii":{"value":null,"code":"TP8ii","title":"Prisons- Needle & syringe programs","descrip":"Are syringe access/exchange programs available in prisons as a matter of national policy?","level":null,"parentCode":"TP8","year":"2021","id":47940,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1i":{"value":0,"code":"S1i","title":"Same-sex sex non-criminalization- Laws","descrip":"Does national law refrain from criminalizing consensual same-sex sexual acts?","level":"not adopted","parentCode":"S1","year":"2021","id":47964,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1ii":{"value":0,"code":"S1ii","title":"Same-sex sex non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided prosecution for consensual same-sex acts in recent years?","level":"not adopted","parentCode":"S1","year":"2021","id":47989,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","parentCode":"S2","year":"2021","id":48015,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","parentCode":"S3","year":"2021","id":48042,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4i":{"value":1,"code":"S4i","title":"HIV exposure non-criminalization- Laws","descrip":"Does national law refrain from criminalizing HIV exposure/transmission?","level":"adopted","parentCode":"S4","year":"2021","id":48070,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4ii":{"value":1,"code":"S4ii","title":"HIV exposure non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided arrests/prosecution for HIV transmission/exposure in recent years?","level":"adopted","parentCode":"S4","year":"2021","id":48099,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5i":{"value":null,"code":"S5i","title":"Non-discrimination- Sexual orientation","descrip":"Do national laws protect people from discrimination on the basis of sexual orientation?","level":null,"parentCode":"S5","year":"2021","id":48129,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5ii":{"value":null,"code":"S5ii","title":"Non-discrimination- Gender identity","descrip":"Do national laws protect people from discrimination on the basis of gender identity/diversity?","level":null,"parentCode":"S5","year":"2021","id":48160,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5iii":{"value":null,"code":"S5iii","title":"Non-discrimination- HIV status","descrip":"Do national laws protect people from discrimination on the basis of HIV status?","level":null,"parentCode":"S5","year":"2021","id":48192,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","parentCode":"S6","year":"2021","id":48225,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","parentCode":"S7","year":"2021","id":48259,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"parentCode":"S8","year":"2021","id":48294,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","parentCode":"S9","year":"2021","id":48330,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10i":{"value":null,"code":"S10i","title":"Civil society- Social contracting","descrip":"Does national policy provide for social contracting (or other mechanisms by which the government finances CSOs to provide health services)?","level":null,"parentCode":"S10","year":"2021","id":48367,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10ii":{"value":0,"code":"S10ii","title":"Civil society- Freedom","descrip":"Are NGOs/CSOs, including those working with key populations, able to officially register, seek funding, and operate freely under national laws and policies?","level":"not adopted","parentCode":"S10","year":"2021","id":48405,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"parentCode":"HS1","year":"2021","id":48444,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2i":{"value":null,"code":"HS2i","title":"Health financing- Budget","descrip":"Does the percent of government spending going to health align with the Global Fund co-financing targets?","level":null,"parentCode":"HS2","year":"2021","id":48484,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2ii":{"value":1,"code":"HS2ii","title":"Health financing- Tax revenue","descrip":"Does government collect adequate tax revenue to align with the tax:GDP ratio in the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2021","id":48525,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3i":{"value":null,"code":"HS3i","title":"UHC- ARVs","descrip":"Are ARVs covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2021","id":48567,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3ii":{"value":null,"code":"HS3ii","title":"UHC- PrEP","descrip":"Is PrEP covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2021","id":48610,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4i":{"value":null,"code":"HS4i","title":"User fees- Primary care","descrip":"Are primary healthcare services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2021","id":48654,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4ii":{"value":null,"code":"HS4ii","title":"User fees- HIV services","descrip":"Are HIV services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2021","id":48699,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5i":{"value":0,"code":"HS5i","title":"TRIPS- Incorporation","descrip":"Are TRIPS flexibilities (including parallel importation, compulsory licensing, and LDC extension) incorporated in national law?","level":"not adopted","parentCode":"HS5","year":"2021","id":48745,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5ii":{"value":0,"code":"HS5ii","title":"TRIPS- Use","descrip":"Are there documented examples of the country utilizing TRIPS flexibilities?","level":"not adopted","parentCode":"HS5","year":"2021","id":48792,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6i":{"value":null,"code":"HS6i","title":"Unique IDs- Use","descrip":"Is there a unique ID (or other method of de-duplicating data) that allows for continuity of care across multiple facilities?","level":null,"parentCode":"HS6","year":"2021","id":48840,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6ii":{"value":null,"code":"HS6ii","title":"Data protections","descrip":"Does national law include legally enforceable protections against disclosure of individually-identifiable health data, including HIV status?","level":null,"parentCode":"HS6","year":"2021","id":48889,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7i":{"value":null,"code":"HS7i","title":"Data sharing- Disaggregation","descrip":"Is data disaggregated by geographic region, age, and gender?","level":null,"parentCode":"HS7","year":"2021","id":48939,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7ii":{"value":null,"code":"HS7ii","title":"Data sharing- Frequency","descrip":"Is data shared at least quarterly?","level":null,"parentCode":"HS7","year":"2021","id":48990,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2022":{"CT1":{"value":null,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":null,"parentCode":"CT1","year":"2022","id":48990,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"parentCode":"CT2","year":"2022","id":48991,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"parentCode":"CT3","year":"2022","id":48993,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4i":{"value":null,"code":"CT4i","title":"Community ART distribution","descrip":"Does national policy allow for community ART distribution?","level":null,"parentCode":"CT4","year":"2022","id":48996,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4ii":{"value":null,"code":"CT4ii","title":"Clinic visit frequency","descrip":"Does national policy allow for reduced frequency of clinical visits?","level":null,"parentCode":"CT4","year":"2022","id":49000,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4iii":{"value":null,"code":"CT4iii","title":"Multi-month dispensing","descrip":"Does national policy allow for multi-month dispensing?","level":null,"parentCode":"CT4","year":"2022","id":49005,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"parentCode":"CT5","year":"2022","id":49011,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6i":{"value":null,"code":"CT6i","title":"Peds- Diagnosis","descrip":"Does early infant diagnosis policy align with WHO recommendations on the use of point-of-care tests?","level":null,"parentCode":"CT6","year":"2022","id":49018,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6ii":{"value":null,"code":"CT6ii","title":"Peds- Treatment","descrip":"Does the first-line ARV regimen for infants and children included in national guidelines align with WHO recommendations?","level":null,"parentCode":"CT6","year":"2022","id":49026,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7i":{"value":1,"code":"CT7i","title":"Migrants-Primary health care","descrip":"Is primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2022","id":49035,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7ii":{"value":1,"code":"CT7ii","title":"Migrants-HIV services","descrip":"Are HIV services available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2022","id":49045,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":null,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":null,"parentCode":"CT8","year":"2022","id":49056,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","parentCode":"TP1","year":"2022","id":49068,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2i":{"value":null,"code":"TP2i","title":"Index testing ","descrip":"Is index testing/partner notification provided for in national guidelines?","level":null,"parentCode":"TP2","year":"2022","id":49081,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2ii":{"value":null,"code":"TP2ii","title":"Confidentiality in index testing","descrip":"Do partner notification guidelines include confidentiality and robust  protections against disclosure of HIV status without patients consent?","level":null,"parentCode":"TP2","year":"2022","id":49095,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"parentCode":"TP3","year":"2022","id":49110,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":null,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":null,"parentCode":"TP4","year":"2022","id":49126,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5i":{"value":0,"code":"TP5i","title":"PrEP-Policy","descrip":"Are people/populations at substantial risk of HIV infection identified and eligible for PrEP under national policy?","level":"not adopted","parentCode":"TP5","year":"2022","id":49143,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5ii":{"value":1,"code":"TP5ii","title":"PrEP-Regulatory approval","descrip":"Has at least one form of PrEP received national regulatory approval?","level":"adopted","parentCode":"TP5","year":"2022","id":49161,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6i":{"value":1,"code":"TP6i","title":"Harm reduction strategy","descrip":"Is harm reduction included in national policy & service packages for people who inject drugs?","level":"adopted","parentCode":"TP6","year":"2022","id":49180,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6ii":{"value":null,"code":"TP6ii","title":"Syringe non-criminalization","descrip":"Does national law avoid imposing criminal penalties for possession of syringes and associated paraphernalia?","level":null,"parentCode":"TP6","year":"2022","id":49200,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"parentCode":"TP7","year":"2022","id":49221,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8i":{"value":1,"code":"TP8i","title":"Prisons- Condoms","descrip":"Are condoms/lubricant available in prisons as a matter of national policy?","level":"adopted","parentCode":"TP8","year":"2022","id":49243,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8ii":{"value":null,"code":"TP8ii","title":"Prisons- Needle & syringe programs","descrip":"Are syringe access/exchange programs available in prisons as a matter of national policy?","level":null,"parentCode":"TP8","year":"2022","id":49266,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1i":{"value":0,"code":"S1i","title":"Same-sex sex non-criminalization- Laws","descrip":"Does national law refrain from criminalizing consensual same-sex sexual acts?","level":"not adopted","parentCode":"S1","year":"2022","id":49290,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1ii":{"value":0,"code":"S1ii","title":"Same-sex sex non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided prosecution for consensual same-sex acts in recent years?","level":"not adopted","parentCode":"S1","year":"2022","id":49315,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","parentCode":"S2","year":"2022","id":49341,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","parentCode":"S3","year":"2022","id":49368,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4i":{"value":1,"code":"S4i","title":"HIV exposure non-criminalization- Laws","descrip":"Does national law refrain from criminalizing HIV exposure/transmission?","level":"adopted","parentCode":"S4","year":"2022","id":49396,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4ii":{"value":1,"code":"S4ii","title":"HIV exposure non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided arrests/prosecution for HIV transmission/exposure in recent years?","level":"adopted","parentCode":"S4","year":"2022","id":49425,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5i":{"value":null,"code":"S5i","title":"Non-discrimination- Sexual orientation","descrip":"Do national laws protect people from discrimination on the basis of sexual orientation?","level":null,"parentCode":"S5","year":"2022","id":49455,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5ii":{"value":null,"code":"S5ii","title":"Non-discrimination- Gender identity","descrip":"Do national laws protect people from discrimination on the basis of gender identity/diversity?","level":null,"parentCode":"S5","year":"2022","id":49486,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5iii":{"value":null,"code":"S5iii","title":"Non-discrimination- HIV status","descrip":"Do national laws protect people from discrimination on the basis of HIV status?","level":null,"parentCode":"S5","year":"2022","id":49518,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","parentCode":"S6","year":"2022","id":49551,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","parentCode":"S7","year":"2022","id":49585,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"parentCode":"S8","year":"2022","id":49620,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","parentCode":"S9","year":"2022","id":49656,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10i":{"value":null,"code":"S10i","title":"Civil society- Social contracting","descrip":"Does national policy provide for social contracting (or other mechanisms by which the government finances CSOs to provide health services)?","level":null,"parentCode":"S10","year":"2022","id":49693,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10ii":{"value":0,"code":"S10ii","title":"Civil society- Freedom","descrip":"Are NGOs/CSOs, including those working with key populations, able to officially register, seek funding, and operate freely under national laws and policies?","level":"not adopted","parentCode":"S10","year":"2022","id":49731,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"parentCode":"HS1","year":"2022","id":49770,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2i":{"value":null,"code":"HS2i","title":"Health financing- Budget","descrip":"Does the percent of government spending going to health align with the Global Fund co-financing targets?","level":null,"parentCode":"HS2","year":"2022","id":49810,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2ii":{"value":1,"code":"HS2ii","title":"Health financing- Tax revenue","descrip":"Does government collect adequate tax revenue to align with the tax:GDP ratio in the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2022","id":49851,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3i":{"value":null,"code":"HS3i","title":"UHC- ARVs","descrip":"Are ARVs covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2022","id":49893,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3ii":{"value":null,"code":"HS3ii","title":"UHC- PrEP","descrip":"Is PrEP covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2022","id":49936,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4i":{"value":null,"code":"HS4i","title":"User fees- Primary care","descrip":"Are primary healthcare services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2022","id":49980,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4ii":{"value":null,"code":"HS4ii","title":"User fees- HIV services","descrip":"Are HIV services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2022","id":50025,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5i":{"value":0,"code":"HS5i","title":"TRIPS- Incorporation","descrip":"Are TRIPS flexibilities (including parallel importation, compulsory licensing, and LDC extension) incorporated in national law?","level":"not adopted","parentCode":"HS5","year":"2022","id":50071,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5ii":{"value":0,"code":"HS5ii","title":"TRIPS- Use","descrip":"Are there documented examples of the country utilizing TRIPS flexibilities?","level":"not adopted","parentCode":"HS5","year":"2022","id":50118,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6i":{"value":null,"code":"HS6i","title":"Unique IDs- Use","descrip":"Is there a unique ID (or other method of de-duplicating data) that allows for continuity of care across multiple facilities?","level":null,"parentCode":"HS6","year":"2022","id":50166,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6ii":{"value":1,"code":"HS6ii","title":"Data protections","descrip":"Does national law include legally enforceable protections against disclosure of individually-identifiable health data, including HIV status?","level":"adopted","parentCode":"HS6","year":"2022","id":50215,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7i":{"value":null,"code":"HS7i","title":"Data sharing- Disaggregation","descrip":"Is data disaggregated by geographic region, age, and gender?","level":null,"parentCode":"HS7","year":"2022","id":50265,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7ii":{"value":null,"code":"HS7ii","title":"Data sharing- Frequency","descrip":"Is data shared at least quarterly?","level":null,"parentCode":"HS7","year":"2022","id":50316,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2023":{"CT1":{"value":null,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":null,"parentCode":"CT1","year":"2023","id":50316,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"parentCode":"CT2","year":"2023","id":50317,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"parentCode":"CT3","year":"2023","id":50319,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4i":{"value":null,"code":"CT4i","title":"Community ART distribution","descrip":"Does national policy allow for community ART distribution?","level":null,"parentCode":"CT4","year":"2023","id":50322,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4ii":{"value":null,"code":"CT4ii","title":"Clinic visit frequency","descrip":"Does national policy allow for reduced frequency of clinical visits?","level":null,"parentCode":"CT4","year":"2023","id":50326,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4iii":{"value":null,"code":"CT4iii","title":"Multi-month dispensing","descrip":"Does national policy allow for multi-month dispensing?","level":null,"parentCode":"CT4","year":"2023","id":50331,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"parentCode":"CT5","year":"2023","id":50337,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6i":{"value":null,"code":"CT6i","title":"Peds- Diagnosis","descrip":"Does early infant diagnosis policy align with WHO recommendations on the use of point-of-care tests?","level":null,"parentCode":"CT6","year":"2023","id":50344,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6ii":{"value":null,"code":"CT6ii","title":"Peds- Treatment","descrip":"Does the first-line ARV regimen for infants and children included in national guidelines align with WHO recommendations?","level":null,"parentCode":"CT6","year":"2023","id":50352,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7i":{"value":1,"code":"CT7i","title":"Migrants-Primary health care","descrip":"Is primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2023","id":50361,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7ii":{"value":1,"code":"CT7ii","title":"Migrants-HIV services","descrip":"Are HIV services available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2023","id":50371,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":null,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":null,"parentCode":"CT8","year":"2023","id":50382,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","parentCode":"TP1","year":"2023","id":50394,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2i":{"value":null,"code":"TP2i","title":"Index testing ","descrip":"Is index testing/partner notification provided for in national guidelines?","level":null,"parentCode":"TP2","year":"2023","id":50407,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2ii":{"value":null,"code":"TP2ii","title":"Confidentiality in index testing","descrip":"Do partner notification guidelines include confidentiality and robust  protections against disclosure of HIV status without patients consent?","level":null,"parentCode":"TP2","year":"2023","id":50421,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"parentCode":"TP3","year":"2023","id":50436,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":null,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":null,"parentCode":"TP4","year":"2023","id":50452,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5i":{"value":0,"code":"TP5i","title":"PrEP-Policy","descrip":"Are people/populations at substantial risk of HIV infection identified and eligible for PrEP under national policy?","level":"not adopted","parentCode":"TP5","year":"2023","id":50469,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5ii":{"value":1,"code":"TP5ii","title":"PrEP-Regulatory approval","descrip":"Has at least one form of PrEP received national regulatory approval?","level":"adopted","parentCode":"TP5","year":"2023","id":50487,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6i":{"value":1,"code":"TP6i","title":"Harm reduction strategy","descrip":"Is harm reduction included in national policy & service packages for people who inject drugs?","level":"adopted","parentCode":"TP6","year":"2023","id":50506,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6ii":{"value":null,"code":"TP6ii","title":"Syringe non-criminalization","descrip":"Does national law avoid imposing criminal penalties for possession of syringes and associated paraphernalia?","level":null,"parentCode":"TP6","year":"2023","id":50526,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"parentCode":"TP7","year":"2023","id":50547,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8i":{"value":1,"code":"TP8i","title":"Prisons- Condoms","descrip":"Are condoms/lubricant available in prisons as a matter of national policy?","level":"adopted","parentCode":"TP8","year":"2023","id":50569,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8ii":{"value":null,"code":"TP8ii","title":"Prisons- Needle & syringe programs","descrip":"Are syringe access/exchange programs available in prisons as a matter of national policy?","level":null,"parentCode":"TP8","year":"2023","id":50592,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1i":{"value":0,"code":"S1i","title":"Same-sex sex non-criminalization- Laws","descrip":"Does national law refrain from criminalizing consensual same-sex sexual acts?","level":"not adopted","parentCode":"S1","year":"2023","id":50616,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1ii":{"value":0,"code":"S1ii","title":"Same-sex sex non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided prosecution for consensual same-sex acts in recent years?","level":"not adopted","parentCode":"S1","year":"2023","id":50641,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","parentCode":"S2","year":"2023","id":50667,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","parentCode":"S3","year":"2023","id":50694,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4i":{"value":1,"code":"S4i","title":"HIV exposure non-criminalization- Laws","descrip":"Does national law refrain from criminalizing HIV exposure/transmission?","level":"adopted","parentCode":"S4","year":"2023","id":50722,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4ii":{"value":1,"code":"S4ii","title":"HIV exposure non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided arrests/prosecution for HIV transmission/exposure in recent years?","level":"adopted","parentCode":"S4","year":"2023","id":50751,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5i":{"value":null,"code":"S5i","title":"Non-discrimination- Sexual orientation","descrip":"Do national laws protect people from discrimination on the basis of sexual orientation?","level":null,"parentCode":"S5","year":"2023","id":50781,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5ii":{"value":null,"code":"S5ii","title":"Non-discrimination- Gender identity","descrip":"Do national laws protect people from discrimination on the basis of gender identity/diversity?","level":null,"parentCode":"S5","year":"2023","id":50812,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5iii":{"value":null,"code":"S5iii","title":"Non-discrimination- HIV status","descrip":"Do national laws protect people from discrimination on the basis of HIV status?","level":null,"parentCode":"S5","year":"2023","id":50844,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","parentCode":"S6","year":"2023","id":50877,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","parentCode":"S7","year":"2023","id":50911,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"parentCode":"S8","year":"2023","id":50946,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","parentCode":"S9","year":"2023","id":50982,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10i":{"value":null,"code":"S10i","title":"Civil society- Social contracting","descrip":"Does national policy provide for social contracting (or other mechanisms by which the government finances CSOs to provide health services)?","level":null,"parentCode":"S10","year":"2023","id":51019,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10ii":{"value":0,"code":"S10ii","title":"Civil society- Freedom","descrip":"Are NGOs/CSOs, including those working with key populations, able to officially register, seek funding, and operate freely under national laws and policies?","level":"not adopted","parentCode":"S10","year":"2023","id":51057,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"parentCode":"HS1","year":"2023","id":51096,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2i":{"value":null,"code":"HS2i","title":"Health financing- Budget","descrip":"Does the percent of government spending going to health align with the Global Fund co-financing targets?","level":null,"parentCode":"HS2","year":"2023","id":51136,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2ii":{"value":1,"code":"HS2ii","title":"Health financing- Tax revenue","descrip":"Does government collect adequate tax revenue to align with the tax:GDP ratio in the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2023","id":51177,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3i":{"value":null,"code":"HS3i","title":"UHC- ARVs","descrip":"Are ARVs covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2023","id":51219,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3ii":{"value":null,"code":"HS3ii","title":"UHC- PrEP","descrip":"Is PrEP covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2023","id":51262,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4i":{"value":null,"code":"HS4i","title":"User fees- Primary care","descrip":"Are primary healthcare services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2023","id":51306,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4ii":{"value":null,"code":"HS4ii","title":"User fees- HIV services","descrip":"Are HIV services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2023","id":51351,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5i":{"value":0,"code":"HS5i","title":"TRIPS- Incorporation","descrip":"Are TRIPS flexibilities (including parallel importation, compulsory licensing, and LDC extension) incorporated in national law?","level":"not adopted","parentCode":"HS5","year":"2023","id":51397,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5ii":{"value":0,"code":"HS5ii","title":"TRIPS- Use","descrip":"Are there documented examples of the country utilizing TRIPS flexibilities?","level":"not adopted","parentCode":"HS5","year":"2023","id":51444,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6i":{"value":null,"code":"HS6i","title":"Unique IDs- Use","descrip":"Is there a unique ID (or other method of de-duplicating data) that allows for continuity of care across multiple facilities?","level":null,"parentCode":"HS6","year":"2023","id":51492,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6ii":{"value":1,"code":"HS6ii","title":"Data protections","descrip":"Does national law include legally enforceable protections against disclosure of individually-identifiable health data, including HIV status?","level":"adopted","parentCode":"HS6","year":"2023","id":51541,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7i":{"value":null,"code":"HS7i","title":"Data sharing- Disaggregation","descrip":"Is data disaggregated by geographic region, age, and gender?","level":null,"parentCode":"HS7","year":"2023","id":51591,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7ii":{"value":null,"code":"HS7ii","title":"Data sharing- Frequency","descrip":"Is data shared at least quarterly?","level":null,"parentCode":"HS7","year":"2023","id":51642,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2024":{"CT1":{"value":null,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":null,"parentCode":"CT1","year":"2024","id":51642,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"parentCode":"CT2","year":"2024","id":51643,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"parentCode":"CT3","year":"2024","id":51645,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4i":{"value":null,"code":"CT4i","title":"Community ART distribution","descrip":"Does national policy allow for community ART distribution?","level":null,"parentCode":"CT4","year":"2024","id":51648,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4ii":{"value":null,"code":"CT4ii","title":"Clinic visit frequency","descrip":"Does national policy allow for reduced frequency of clinical visits?","level":null,"parentCode":"CT4","year":"2024","id":51652,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4iii":{"value":null,"code":"CT4iii","title":"Multi-month dispensing","descrip":"Does national policy allow for multi-month dispensing?","level":null,"parentCode":"CT4","year":"2024","id":51657,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"parentCode":"CT5","year":"2024","id":51663,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6i":{"value":null,"code":"CT6i","title":"Peds- Diagnosis","descrip":"Does early infant diagnosis policy align with WHO recommendations on the use of point-of-care tests?","level":null,"parentCode":"CT6","year":"2024","id":51670,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6ii":{"value":null,"code":"CT6ii","title":"Peds- Treatment","descrip":"Does the first-line ARV regimen for infants and children included in national guidelines align with WHO recommendations?","level":null,"parentCode":"CT6","year":"2024","id":51678,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7i":{"value":1,"code":"CT7i","title":"Migrants-Primary health care","descrip":"Is primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2024","id":54339,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7ii":{"value":1,"code":"CT7ii","title":"Migrants-HIV services","descrip":"Are HIV services available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2024","id":54349,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":null,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":null,"parentCode":"CT8","year":"2024","id":51708,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","parentCode":"TP1","year":"2024","id":54372,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2i":{"value":null,"code":"TP2i","title":"Index testing ","descrip":"Is index testing/partner notification provided for in national guidelines?","level":null,"parentCode":"TP2","year":"2024","id":51733,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2ii":{"value":null,"code":"TP2ii","title":"Confidentiality in index testing","descrip":"Do partner notification guidelines include confidentiality and robust  protections against disclosure of HIV status without patients consent?","level":null,"parentCode":"TP2","year":"2024","id":51747,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"parentCode":"TP3","year":"2024","id":51762,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":null,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":null,"parentCode":"TP4","year":"2024","id":51778,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5i":{"value":0,"code":"TP5i","title":"PrEP-Policy","descrip":"Are people/populations at substantial risk of HIV infection identified and eligible for PrEP under national policy?","level":"not adopted","parentCode":"TP5","year":"2024","id":54447,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5ii":{"value":1,"code":"TP5ii","title":"PrEP-Regulatory approval","descrip":"Has at least one form of PrEP received national regulatory approval?","level":"adopted","parentCode":"TP5","year":"2024","id":54465,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6i":{"value":1,"code":"TP6i","title":"Harm reduction strategy","descrip":"Is harm reduction included in national policy & service packages for people who inject drugs?","level":"adopted","parentCode":"TP6","year":"2024","id":54484,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6ii":{"value":null,"code":"TP6ii","title":"Syringe non-criminalization","descrip":"Does national law avoid imposing criminal penalties for possession of syringes and associated paraphernalia?","level":null,"parentCode":"TP6","year":"2024","id":51852,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"parentCode":"TP7","year":"2024","id":51873,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8i":{"value":1,"code":"TP8i","title":"Prisons- Condoms","descrip":"Are condoms/lubricant available in prisons as a matter of national policy?","level":"adopted","parentCode":"TP8","year":"2024","id":54547,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8ii":{"value":null,"code":"TP8ii","title":"Prisons- Needle & syringe programs","descrip":"Are syringe access/exchange programs available in prisons as a matter of national policy?","level":null,"parentCode":"TP8","year":"2024","id":51918,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1i":{"value":0,"code":"S1i","title":"Same-sex sex non-criminalization- Laws","descrip":"Does national law refrain from criminalizing consensual same-sex sexual acts?","level":"not adopted","parentCode":"S1","year":"2024","id":54594,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1ii":{"value":0,"code":"S1ii","title":"Same-sex sex non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided prosecution for consensual same-sex acts in recent years?","level":"not adopted","parentCode":"S1","year":"2024","id":54619,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","parentCode":"S2","year":"2024","id":54645,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","parentCode":"S3","year":"2024","id":54672,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4i":{"value":1,"code":"S4i","title":"HIV exposure non-criminalization- Laws","descrip":"Does national law refrain from criminalizing HIV exposure/transmission?","level":"adopted","parentCode":"S4","year":"2024","id":54700,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4ii":{"value":1,"code":"S4ii","title":"HIV exposure non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided arrests/prosecution for HIV transmission/exposure in recent years?","level":"adopted","parentCode":"S4","year":"2024","id":54729,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5i":{"value":null,"code":"S5i","title":"Non-discrimination- Sexual orientation","descrip":"Do national laws protect people from discrimination on the basis of sexual orientation?","level":null,"parentCode":"S5","year":"2024","id":52107,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5ii":{"value":null,"code":"S5ii","title":"Non-discrimination- Gender identity","descrip":"Do national laws protect people from discrimination on the basis of gender identity/diversity?","level":null,"parentCode":"S5","year":"2024","id":52138,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5iii":{"value":null,"code":"S5iii","title":"Non-discrimination- HIV status","descrip":"Do national laws protect people from discrimination on the basis of HIV status?","level":null,"parentCode":"S5","year":"2024","id":52170,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","parentCode":"S6","year":"2024","id":54855,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","parentCode":"S7","year":"2024","id":54889,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"parentCode":"S8","year":"2024","id":52272,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","parentCode":"S9","year":"2024","id":54960,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10i":{"value":null,"code":"S10i","title":"Civil society- Social contracting","descrip":"Does national policy provide for social contracting (or other mechanisms by which the government finances CSOs to provide health services)?","level":null,"parentCode":"S10","year":"2024","id":52345,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10ii":{"value":0,"code":"S10ii","title":"Civil society- Freedom","descrip":"Are NGOs/CSOs, including those working with key populations, able to officially register, seek funding, and operate freely under national laws and policies?","level":"not adopted","parentCode":"S10","year":"2024","id":55035,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"parentCode":"HS1","year":"2024","id":52422,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2i":{"value":null,"code":"HS2i","title":"Health financing- Budget","descrip":"Does the percent of government spending going to health align with the Global Fund co-financing targets?","level":null,"parentCode":"HS2","year":"2024","id":52462,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2ii":{"value":1,"code":"HS2ii","title":"Health financing- Tax revenue","descrip":"Does government collect adequate tax revenue to align with the tax:GDP ratio in the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2024","id":55155,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3i":{"value":null,"code":"HS3i","title":"UHC- ARVs","descrip":"Are ARVs covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2024","id":52545,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3ii":{"value":null,"code":"HS3ii","title":"UHC- PrEP","descrip":"Is PrEP covered by the national health system/scheme?","level":null,"parentCode":"HS3","year":"2024","id":52588,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4i":{"value":null,"code":"HS4i","title":"User fees- Primary care","descrip":"Are primary healthcare services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2024","id":52632,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4ii":{"value":null,"code":"HS4ii","title":"User fees- HIV services","descrip":"Are HIV services in public facilities available without user fees?","level":null,"parentCode":"HS4","year":"2024","id":52677,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5i":{"value":0,"code":"HS5i","title":"TRIPS- Incorporation","descrip":"Are TRIPS flexibilities (including parallel importation, compulsory licensing, and LDC extension) incorporated in national law?","level":"not adopted","parentCode":"HS5","year":"2024","id":55375,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5ii":{"value":0,"code":"HS5ii","title":"TRIPS- Use","descrip":"Are there documented examples of the country utilizing TRIPS flexibilities?","level":"not adopted","parentCode":"HS5","year":"2024","id":55422,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6i":{"value":null,"code":"HS6i","title":"Unique IDs- Use","descrip":"Is there a unique ID (or other method of de-duplicating data) that allows for continuity of care across multiple facilities?","level":null,"parentCode":"HS6","year":"2024","id":52818,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6ii":{"value":1,"code":"HS6ii","title":"Data protections","descrip":"Does national law include legally enforceable protections against disclosure of individually-identifiable health data, including HIV status?","level":"adopted","parentCode":"HS6","year":"2024","id":55519,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7i":{"value":null,"code":"HS7i","title":"Data sharing- Disaggregation","descrip":"Is data disaggregated by geographic region, age, and gender?","level":null,"parentCode":"HS7","year":"2024","id":52917,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7ii":{"value":null,"code":"HS7ii","title":"Data sharing- Frequency","descrip":"Is data shared at least quarterly?","level":null,"parentCode":"HS7","year":"2024","id":52968,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"years":{"CT1":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT2":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT3":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT4i":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT4ii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT4iii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT5":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT6i":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT6ii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT7i":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT7ii":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT8":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP1":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP2i":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP2ii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP3":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP4":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP5i":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP5ii":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP6i":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP6ii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP7":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP8i":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP8ii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S1i":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S1ii":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S2":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S3":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S4i":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S4ii":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S5i":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S5ii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S5iii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S6":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S7":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S8":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S9":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S10i":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S10ii":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS1":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS2i":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS2ii":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS3i":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS3ii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS4i":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS4ii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS5i":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS5ii":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS6i":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS6ii":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS7i":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS7ii":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}]},"recent":{"CT1":{"value":1,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":"adopted","parentCode":"CT1","year":"2020","id":54294,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"year":null,"title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","code":"CT2","parentCode":"CT2","id":54295,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":0,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":"not adopted","parentCode":"CT3","year":"2019","id":54297,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4i":{"value":0,"code":"CT4i","title":"Community ART distribution","descrip":"Does national policy allow for community ART distribution?","level":"not adopted","parentCode":"CT4","year":"2020","id":54300,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4ii":{"value":0.5,"code":"CT4ii","title":"Clinic visit frequency","descrip":"Does national policy allow for reduced frequency of clinical visits?","level":"partial","parentCode":"CT4","year":"2018","id":54304,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4iii":{"value":0.5,"code":"CT4iii","title":"Multi-month dispensing","descrip":"Does national policy allow for multi-month dispensing?","level":"partial","parentCode":"CT4","year":"2020","id":54309,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":1,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":"adopted","parentCode":"CT5","year":"2018","id":54315,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6i":{"value":1,"code":"CT6i","title":"Peds- Diagnosis","descrip":"Does early infant diagnosis policy align with WHO recommendations on the use of point-of-care tests?","level":"adopted","parentCode":"CT6","year":"2017","id":54322,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6ii":{"value":1,"code":"CT6ii","title":"Peds- Treatment","descrip":"Does the first-line ARV regimen for infants and children included in national guidelines align with WHO recommendations?","level":"adopted","parentCode":"CT6","year":"2017","id":54330,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7i":{"value":1,"code":"CT7i","title":"Migrants-Primary health care","descrip":"Is primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2024","id":54339,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7ii":{"value":1,"code":"CT7ii","title":"Migrants-HIV services","descrip":"Are HIV services available to all migrants under the same conditions as citizens under national policy?","level":"adopted","parentCode":"CT7","year":"2024","id":54349,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":0,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":"not adopted","parentCode":"CT8","year":"2020","id":54360,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","parentCode":"TP1","year":"2024","id":54372,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2i":{"value":1,"code":"TP2i","title":"Index testing ","descrip":"Is index testing/partner notification provided for in national guidelines?","level":"adopted","parentCode":"TP2","year":"2020","id":54385,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2ii":{"value":null,"year":null,"title":"Confidentiality in index testing","descrip":"Do partner notification guidelines include confidentiality and robust  protections against disclosure of HIV status without patients consent?","code":"TP2ii","parentCode":"TP2","id":54399,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":1,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":"adopted","parentCode":"TP3","year":"2018","id":54414,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":0,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":"not adopted","parentCode":"TP4","year":"2019","id":54430,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5i":{"value":0,"code":"TP5i","title":"PrEP-Policy","descrip":"Are people/populations at substantial risk of HIV infection identified and eligible for PrEP under national policy?","level":"not adopted","parentCode":"TP5","year":"2024","id":54447,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5ii":{"value":1,"code":"TP5ii","title":"PrEP-Regulatory approval","descrip":"Has at least one form of PrEP received national regulatory approval?","level":"adopted","parentCode":"TP5","year":"2024","id":54465,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6i":{"value":1,"code":"TP6i","title":"Harm reduction strategy","descrip":"Is harm reduction included in national policy & service packages for people who inject drugs?","level":"adopted","parentCode":"TP6","year":"2024","id":54484,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6ii":{"value":1,"code":"TP6ii","title":"Syringe non-criminalization","descrip":"Does national law avoid imposing criminal penalties for possession of syringes and associated paraphernalia?","level":"adopted","parentCode":"TP6","year":"2017","id":54504,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":1,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":"adopted","parentCode":"TP7","year":"2019","id":54525,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8i":{"value":1,"code":"TP8i","title":"Prisons- Condoms","descrip":"Are condoms/lubricant available in prisons as a matter of national policy?","level":"adopted","parentCode":"TP8","year":"2024","id":54547,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8ii":{"value":0,"code":"TP8ii","title":"Prisons- Needle & syringe programs","descrip":"Are syringe access/exchange programs available in prisons as a matter of national policy?","level":"not adopted","parentCode":"TP8","year":"2020","id":54570,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1i":{"value":0,"code":"S1i","title":"Same-sex sex non-criminalization- Laws","descrip":"Does national law refrain from criminalizing consensual same-sex sexual acts?","level":"not adopted","parentCode":"S1","year":"2024","id":54594,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1ii":{"value":0,"code":"S1ii","title":"Same-sex sex non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided prosecution for consensual same-sex acts in recent years?","level":"not adopted","parentCode":"S1","year":"2024","id":54619,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","parentCode":"S2","year":"2024","id":54645,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","parentCode":"S3","year":"2024","id":54672,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4i":{"value":1,"code":"S4i","title":"HIV exposure non-criminalization- Laws","descrip":"Does national law refrain from criminalizing HIV exposure/transmission?","level":"adopted","parentCode":"S4","year":"2024","id":54700,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4ii":{"value":1,"code":"S4ii","title":"HIV exposure non-criminalization- Arrests","descrip":"Has law-enforcement policy avoided arrests/prosecution for HIV transmission/exposure in recent years?","level":"adopted","parentCode":"S4","year":"2024","id":54729,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5i":{"value":0,"code":"S5i","title":"Non-discrimination- Sexual orientation","descrip":"Do national laws protect people from discrimination on the basis of sexual orientation?","level":"not adopted","parentCode":"S5","year":"2019","id":54759,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5ii":{"value":0,"code":"S5ii","title":"Non-discrimination- Gender identity","descrip":"Do national laws protect people from discrimination on the basis of gender identity/diversity?","level":"not adopted","parentCode":"S5","year":"2017","id":54790,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5iii":{"value":null,"year":null,"title":"Non-discrimination- HIV status","descrip":"Do national laws protect people from discrimination on the basis of HIV status?","code":"S5iii","parentCode":"S5","id":54822,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","parentCode":"S6","year":"2024","id":54855,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","parentCode":"S7","year":"2024","id":54889,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"year":null,"title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","code":"S8","parentCode":"S8","id":54924,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","parentCode":"S9","year":"2024","id":54960,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10i":{"value":1,"code":"S10i","title":"Civil society- Social contracting","descrip":"Does national policy provide for social contracting (or other mechanisms by which the government finances CSOs to provide health services)?","level":"adopted","parentCode":"S10","year":"2018","id":54997,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10ii":{"value":0,"code":"S10ii","title":"Civil society- Freedom","descrip":"Are NGOs/CSOs, including those working with key populations, able to officially register, seek funding, and operate freely under national laws and policies?","level":"not adopted","parentCode":"S10","year":"2024","id":55035,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":0,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":"not adopted","parentCode":"HS1","year":"2017","id":55074,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2i":{"value":1,"code":"HS2i","title":"Health financing- Budget","descrip":"Does the percent of government spending going to health align with the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2019","id":55114,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2ii":{"value":1,"code":"HS2ii","title":"Health financing- Tax revenue","descrip":"Does government collect adequate tax revenue to align with the tax:GDP ratio in the Global Fund co-financing targets?","level":"adopted","parentCode":"HS2","year":"2024","id":55155,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3i":{"value":null,"year":null,"title":"UHC- ARVs","descrip":"Are ARVs covered by the national health system/scheme?","code":"HS3i","parentCode":"HS3","id":55197,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3ii":{"value":null,"year":null,"title":"UHC- PrEP","descrip":"Is PrEP covered by the national health system/scheme?","code":"HS3ii","parentCode":"HS3","id":55240,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4i":{"value":null,"year":null,"title":"User fees- Primary care","descrip":"Are primary healthcare services in public facilities available without user fees?","code":"HS4i","parentCode":"HS4","id":55284,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4ii":{"value":null,"year":null,"title":"User fees- HIV services","descrip":"Are HIV services in public facilities available without user fees?","code":"HS4ii","parentCode":"HS4","id":55329,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5i":{"value":0,"code":"HS5i","title":"TRIPS- Incorporation","descrip":"Are TRIPS flexibilities (including parallel importation, compulsory licensing, and LDC extension) incorporated in national law?","level":"not adopted","parentCode":"HS5","year":"2024","id":55375,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5ii":{"value":0,"code":"HS5ii","title":"TRIPS- Use","descrip":"Are there documented examples of the country utilizing TRIPS flexibilities?","level":"not adopted","parentCode":"HS5","year":"2024","id":55422,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6i":{"value":0,"code":"HS6i","title":"Unique IDs- Use","descrip":"Is there a unique ID (or other method of de-duplicating data) that allows for continuity of care across multiple facilities?","level":"not adopted","parentCode":"HS6","year":"2020","id":55470,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6ii":{"value":1,"code":"HS6ii","title":"Data protections","descrip":"Does national law include legally enforceable protections against disclosure of individually-identifiable health data, including HIV status?","level":"adopted","parentCode":"HS6","year":"2024","id":55519,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7i":{"value":null,"year":null,"title":"Data sharing- Disaggregation","descrip":"Is data disaggregated by geographic region, age, and gender?","code":"HS7i","parentCode":"HS7","id":55569,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7ii":{"value":null,"year":null,"title":"Data sharing- Frequency","descrip":"Is data shared at least quarterly?","code":"HS7ii","parentCode":"HS7","id":55620,"has_subs":false,"type":"Subindicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}}},"refs":{"2017":{"TP5ii":["citation_2017_Algeria_National HIV Care Guidelines","attachment_https://monqcle.com/upload/667497ed9cd360e8618b4573/download"],"S10ii":["Freedom House (2017)"],"S6":["GANHRI (2017)"],"HS2i":["GHED (2017)"],"HS2ii":["Heritage Foundation(2017)"],"S4i":["HIV Justice Network (2016)","NCPI Part A (2017)"],"S4ii":["HIV Justice Network (2021)"],"TP1":["HIVST.org (2018)"],"S5i":["ILGA (2017)"],"S1i":["ILGA (2017)","NCPI Part A (2017)"],"S1ii":["ILGA (2017)","NCPI Part B (2017)"],"CT3":["NCPI (2017)"],"S3":["NCPI (2017)"],"HS6i":["NCPI (2018)"],"CT1":["NCPI Part A (2017)"],"CT4i":["NCPI Part A (2017)"],"CT4ii":["NCPI Part A (2017)"],"CT4iii":["NCPI Part A (2017)"],"CT5":["NCPI Part A (2017)"],"CT6ii":["NCPI Part A (2017)"],"CT6i":["NCPI Part A (2017)"],"HS1":["NCPI Part A (2017)"],"S10i":["NCPI Part A (2017)"],"S5ii":["NCPI Part A (2017)"],"TP2i":["NCPI Part A (2017)"],"TP3":["NCPI Part A (2017)"],"TP4":["NCPI Part A (2017)"],"TP5i":["NCPI Part A (2017)"],"TP6i":["NCPI Part A (2017)"],"TP7":["NCPI Part A (2017)"],"TP6ii":["NCPI Part A (2017)","NCPI Part B (2017)"],"TP8ii":["NCPI Part B (2017)","NCPI Part A (2017)"],"TP8i":["NCPI Part B (2017)","NCPI Part A (2017)"],"S2":["NSWP (2016)","NCPI Part A (2017)"],"CT8":["WHO TB (2017)"],"S9":["World Bank Women Business and the Law (2017)"]},"2018":{"TP5ii":["citation_2017_Algeria_National HIV Care Guidelines","attachment_https://monqcle.com/upload/66749a249cd36059628b4569/download"],"S9":["citation_Algeria Violence Against Women","World Bank Women Business and the Law (2018)","attachment_https://monqcle.com/upload/5f2e1500696352223f9e80f2/download"],"S7":["Constitute (2018)"],"S10ii":["Freedom House (2018)"],"S6":["GANHRI (2017)"],"HS2ii":["Heritage Foundation(2018)"],"S4ii":["HIV Justice Network (2016)"],"S4i":["HIV Justice Network (2016)","NCPI Part A (2017)"],"TP1":["HIVST.org (2018)"],"TP6i":["HRI (2018)"],"TP8ii":["HRI (2018)"],"S5i":["ILGA (2017)"],"S1i":["ILGA (2017)","NCPI Part A (2017)"],"S1ii":["ILGA (2019)"],"S3":["NCPI (2017)"],"CT4i":["NCPI (2018)"],"CT4iii":["NCPI (2018)"],"HS6i":["NCPI (2018)"],"CT4ii":["NCPI Part A (2017)"],"CT1":["NCPI Part A (2018)"],"CT5":["NCPI Part A (2018)"],"S10i":["NCPI Part A (2018)"],"TP2i":["NCPI Part A (2018)"],"TP3":["NCPI Part A (2018)"],"TP4":["NCPI Part A (2018)"],"TP5i":["NCPI Part A (2018)"],"S2":["NSWP (2016)","NCPI Part A (2017)"],"HS2i":["WHO GHED (2018)"],"CT8":["WHO TB (2018)"]},"2019":{"TP5i":["citation_2017_Algeria_National_HIV Care Guidelines","Amel Zertal, Othmane Bourouba, Adel Zeddam, Christophe Broqua, Sandrine Musso. Stories of the fight against HIV/AIDS in Algeria. The Year of the Maghreb, 2021, 25, pp.41-57. 10.4000/, NCPI 2017 anneemaghreb.7830. hal-03513744","attachment_https://monqcle.com/upload/667453379cd360115d8b457e/download"],"TP5ii":["citation_2017_Algeria_National_HIV Care Guidelines","attachment_https://monqcle.com/upload/667453379cd360115d8b457e/download"],"S1i":["citation_Algeria Penal Code (2009)","ILGA (2019)","NCPI Part A (2019)","attachment_https://monqcle.com/upload/5f2e13e0696352223f9e7f24/download"],"S2":["citation_Algeria Penal Code (2009)","NSWP (2019)","attachment_https://monqcle.com/upload/5f2e13e0696352223f9e7f24/download"],"S7":["Algeria Constitution 1989 (reinst. 1996, rev. 2016)"],"S10ii":["Freedom House (2019)"],"S6":["GANHRI (2019)"],"HS2ii":["Heritage Foundation(2019)"],"S4i":["HIV Justice Network (2019)"],"S4ii":["HIV Justice Network (2021)"],"TP1":["HIVST.org (2019)","NCPI Part A (2019)"],"TP6i":["HRI (2019)"],"TP8ii":["HRI (2019)"],"S3":["IDPC (2019)"],"S1ii":["ILGA (2019)"],"S5i":["ILGA (2019)"],"CT4i":["NCPI (2018)"],"CT4iii":["NCPI (2018)"],"HS6i":["NCPI (2018)"],"CT3":["NCPI (2019)"],"TP4":["NCPI Part A (2018)"],"CT1":["NCPI Part A (2019)"],"TP2i":["NCPI Part A (2019)"],"TP7":["NCPI Part A (2019)"],"CT8":["WHO TB (2018)"],"S9":["World Bank Women Business and the Law (2019)"]},"2020":{"TP5ii":["citation_2017_Algeria_National HIV Care Guidelines","attachment_https://monqcle.com/upload/66749ada9cd360e8618b457c/download"],"CT7ii":["citation_AFRO Migrant Health Practices Report (2018)","attachment_https://monqcle.com/upload/5f6a1db0f5f53c511c8b4572/download"],"CT7i":["citation_AFRO Migrant Health Practices Report (2018)","attachment_https://monqcle.com/upload/5f6a1db0f5f53c511c8b4572/download"],"TP8i":["citation_Moazen et al (2019)","attachment_https://monqcle.com/upload/5f08d588f5f53c636a8b45a5/download"],"TP5i":["Amel Zertal, Othmane Bourouba, Adel Zeddam, Christophe Broqua, Sandrine Musso. Stories of the fight against HIV/AIDS in Algeria. The Year of the Maghreb, 2021, 25, pp.41-57. 10.4000/, NCPI 2017 anneemaghreb.7830. hal-03513744"],"HS5i":["article 49 of Ordonnance n° 03-07 2003 relative aux brevets d'invention"],"S7":["Constitute (2018)"],"S10ii":["Freedom House (2020)"],"S6":["GANHRI (2019)"],"HS2ii":["Heritage Foundation (2020)"],"S4i":["HIV  Justice Network (2020)"],"S4ii":["HIV Justice Network (2020)"],"TP6i":["HRI (2020)"],"TP8ii":["HRI (2020)"],"S1ii":["ILGA (2019)"],"S1i":["ILGA (2020)"],"HS6i":["NCPI (2018)"],"TP1":["NCPI (2020)"],"CT1":["NCPI Part A (2019)"],"TP2i":["NCPI Part A (2019)"],"S2":["NSWP (2020)"],"CT4i":["UNAIDS COVID Portal (2020)"],"CT4iii":["UNAIDS COVID Portal (2020)"],"CT8":["WHO Global TB Report (2020)"],"S9":["World Bank Women Business and the Law (2019)"]},"2021":{"TP5i":["citation_2017_Algeria_National_HIV Care Guidelines","Amel Zertal, Othmane Bourouba, Adel Zeddam, Christophe Broqua, Sandrine Musso. Stories of the fight against HIV/AIDS in Algeria. The Year of the Maghreb, 2021, 25, pp.41-57. 10.4000/, NCPI 2017 anneemaghreb.7830. hal-03513744","attachment_https://monqcle.com/upload/667469839cd360dc5e8b456b/download"],"TP5ii":["citation_2017_Algeria_National_HIV Care Guidelines","attachment_https://monqcle.com/upload/667469839cd360dc5e8b456b/download"],"CT7i":["citation_AFRO Migrant Health Practices Report (2018)","attachment_https://monqcle.com/upload/5f6a1db0f5f53c511c8b4572/download"],"S9":["citation_Algeria_National Strategy for Combatting Violence Against Women","World Bank Women Business and the Law (2021)","attachment_https://monqcle.com/upload/603d73b6f5f53cde6e8b4567/download"],"S1i":["citation_Algeria_Penal Code_2009","ILGA(2021)"],"TP8i":["citation_Moazen et al (2019)","attachment_https://monqcle.com/upload/5f08d588f5f53c636a8b45a5/download"],"HS5i":["citation_Motari et al (2021)","article 49 of Ordonnance n° 03-07 2003 relative aux brevets d'invention","attachment_https://monqcle.com/upload/61840dfb9cd36038118b459b/download"],"S7":["Constitute (2018)"],"S10ii":["Freedom House (2021)"],"S6":["GANHRI (2021)"],"HS2ii":["Heritage Foundation (2021)"],"S4ii":["HIV Justice Network (2020)"],"S4i":["HIV Justice Network (2021)"],"S3":["IDPC (2021)"],"S1ii":["ILGA (2021)"],"HS5ii":["Medicines, Law & Policy (2021)"],"S2":["NCPI (2021)"],"TP1":["NCPI (2021)"]},"2022":{"TP5ii":["citation_2017_Algeria_National_HIV Care Guidelines"],"TP5i":["citation_2017_Algeria_National_HIV Care Guidelines"],"HS2ii":["citation_(2022) Heritage Foundation index2022_data","Heritage Foundation (2022)","attachment_https://monqcle.com/upload/63ae060e9cd360db668b4574/download"],"CT7ii":["citation_AFRO Migrant Health Practices Report (2018)","attachment_https://monqcle.com/upload/5f6a1db0f5f53c511c8b4572/download"],"CT7i":["citation_AFRO Migrant Health Practices Report (2018)","attachment_https://monqcle.com/upload/5f6a1db0f5f53c511c8b4572/download"],"S9":["citation_Algeria_National Strategy for Combatting Violence Against Women","World Bank Women Business and the Law (2022)","attachment_https://monqcle.com/upload/603d73b6f5f53cde6e8b4567/download"],"S1i":["citation_Algeria_Penal Code_2009","NCPI Part A (2022)","ILGA(2021)"],"TP8i":["citation_Moazen et al (2019)","attachment_https://monqcle.com/upload/5f08d588f5f53c636a8b45a5/download"],"HS5i":["citation_Motari et al (2021)","article 49 of Ordonnance n° 03-07 2003 relative aux brevets d'invention","attachment_https://monqcle.com/upload/61840dfb9cd36038118b459b/download"],"HS6ii":["(2022)_DLA_Piper_Data_Protections_and_Laws_Handbook"],"S10ii":["(2022)_Freedom_in_the_world_All_data_2013-2022"],"TP6i":["(2022)_The_Global_State_of_Harm_Reduction"],"S7":["Constitute (2018)"],"S6":["GANHRI (2022)"],"S4ii":["HIV Justice Network (2020)"],"S4i":["HIV Justice Network (2021)"],"S3":["IDPC (2021)"],"S1ii":["ILGA (2021)"],"HS5ii":["Medicines, Law & Policy (2021)"],"TP1":["NCPI (2021)"],"S2":["NCPI (2021)","NSWP (2022)","NCPI Part A (2022)"]},"2023":{"TP5i":["citation_2017_Algeria_National_HIV Care Guidelines","Amel Zertal, Othmane Bourouba, Adel Zeddam, Christophe Broqua, Sandrine Musso. Stories of the fight against HIV/AIDS in Algeria. The Year of the Maghreb, 2021, 25, pp.41-57. 10.4000/, NCPI 2017 anneemaghreb.7830. hal-03513744","attachment_https://monqcle.com/upload/66746b049cd360f05e8b456b/download"],"TP5ii":["citation_2017_Algeria_National_HIV Care Guidelines","attachment_https://monqcle.com/upload/66746b049cd360f05e8b456b/download"],"HS2ii":["citation_(2022) Heritage Foundation index2022_data","Heritage Foundation (2022)","attachment_https://monqcle.com/upload/63ae060e9cd360db668b4574/download"],"CT7ii":["citation_AFRO Migrant Health Practices Report (2018)","attachment_https://monqcle.com/upload/5f6a1db0f5f53c511c8b4572/download"],"CT7i":["citation_AFRO Migrant Health Practices Report (2018)","attachment_https://monqcle.com/upload/5f6a1db0f5f53c511c8b4572/download"],"S9":["citation_Algeria_National Strategy for Combatting Violence Against Women","World Bank Women Business and the Law (2023)","attachment_https://monqcle.com/upload/603d73b6f5f53cde6e8b4567/download"],"S1i":["citation_Algeria_Penal Code_2009","NCPI Part A (2022)","ILGA(2021)","attachment_https://monqcle.com/upload/648ca5529cd3604e788b4579/download"],"TP8i":["citation_Moazen et al (2019)","attachment_https://monqcle.com/upload/5f08d588f5f53c636a8b45a5/download"],"HS5i":["citation_Motari et al (2021)","article 49 of Ordonnance n° 03-07 2003 relative aux brevets d'invention","attachment_https://monqcle.com/upload/61840dfb9cd36038118b459b/download"],"HS6ii":["(2022)_DLA_Piper_Data_Protections_and_Laws_Handbook"],"S10ii":["(2022)_Freedom_in_the_world_All_data_2013-2022"],"TP6i":["(2022)_The_Global_State_of_Harm_Reduction"],"S7":["Constitute (2018)"],"S6":["GANHRI (2023)"],"S4i":["HIV Justice Network (2020)"],"S4ii":["HIV Justice Network (2020)"],"S3":["IDPC (2021)"],"S1ii":["ILGA (2023)"],"S5ii":["ILGA (2023)"],"S5i":["ILGA (2023)"],"HS5ii":["Medicines, Law & Policy (2021)"],"TP1":["NCPI (2021)"],"S2":["NCPI (2021)","NSWP (2023)","NCPI Part A (2022)"]},"2024":{"TP5ii":["citation_2017_Algeria_National_HIV Care Guidelines","attachment_https://monqcle.com/upload/6675a58f9cd360e3768b4567/download"],"TP5i":["citation_2017_Algeria_National_HIV Care Guidelines","attachment_https://monqcle.com/upload/6675a58f9cd360e3768b4567/download"],"HS2ii":["citation_(2022) Heritage Foundation index2022_data","Heritage Foundation (2022)","attachment_https://monqcle.com/upload/63ae060e9cd360db668b4574/download"],"CT7ii":["citation_AFRO Migrant Health Practices Report (2018)","attachment_https://monqcle.com/upload/5f6a1db0f5f53c511c8b4572/download"],"CT7i":["citation_AFRO Migrant Health Practices Report (2018)","attachment_https://monqcle.com/upload/5f6a1db0f5f53c511c8b4572/download"],"S9":["citation_Algeria_National Strategy for Combatting Violence Against Women","World Bank Women Business and the Law (2023)","attachment_https://monqcle.com/upload/603d73b6f5f53cde6e8b4567/download"],"S1i":["citation_Algeria_Penal Code_2009","NCPI Part A (2022)","ILGA(2021)","attachment_https://monqcle.com/upload/648ca5529cd3604e788b4579/download"],"TP8i":["citation_Moazen et al (2019)","attachment_https://monqcle.com/upload/5f08d588f5f53c636a8b45a5/download"],"HS5i":["citation_Motari et al (2021)","article 49 of Ordonnance n° 03-07 2003 relative aux brevets d'invention","attachment_https://monqcle.com/upload/61840dfb9cd36038118b459b/download"],"HS6ii":["(2022)_DLA_Piper_Data_Protections_and_Laws_Handbook"],"S10ii":["(2022)_Freedom_in_the_world_All_data_2013-2022"],"TP6i":["(2022)_The_Global_State_of_Harm_Reduction"],"S7":["Constitute (2018)"],"S6":["GANHRI (2023)"],"S4i":["HIV Justice Network (2020)"],"S4ii":["HIV Justice Network (2020)"],"S3":["IDPC (2021)"],"S1ii":["ILGA (2023)"],"S5ii":["ILGA (2023)"],"S5i":["ILGA (2023)"],"HS5ii":["Medicines, Law & Policy (2021)"],"TP1":["NCPI (2021)"],"S2":["NCPI (2021)","NSWP (2023)","NCPI Part A (2022)"]}},"iso2":"DZ","place_name":"Algeria","overall":{"2017":{"data_source":"overall","date_time":"2017","definition":"overall metrics with threshold","metric":"overall","observation_id":1194,"place_fips":null,"place_id":67,"place_iso":"DZ","place_name":"Algeria","stale_flag":false,"updated_at":"Fri, 19 Jul 2024 00:00:00 GMT","value":46},"2018":{"data_source":"overall","date_time":"2018","definition":"overall metrics with threshold","metric":"overall","observation_id":562,"place_fips":null,"place_id":67,"place_iso":"DZ","place_name":"Algeria","stale_flag":false,"updated_at":"Fri, 19 Jul 2024 00:00:00 GMT","value":46},"2019":{"data_source":"overall","date_time":"2019","definition":"overall metrics with threshold","metric":"overall","observation_id":868,"place_fips":null,"place_id":67,"place_iso":"DZ","place_name":"Algeria","stale_flag":false,"updated_at":"Fri, 19 Jul 2024 00:00:00 GMT","value":37},"2020":{"data_source":"overall","date_time":"2020","definition":"overall metrics with threshold","metric":"overall","observation_id":1231,"place_fips":null,"place_id":67,"place_iso":"DZ","place_name":"Algeria","stale_flag":false,"updated_at":"Fri, 19 Jul 2024 00:00:00 GMT","value":47},"2021":{"data_source":"overall","date_time":"2021","definition":"overall metrics with threshold","metric":"overall","observation_id":321,"place_fips":null,"place_id":67,"place_iso":"DZ","place_name":"Algeria","stale_flag":false,"updated_at":"Fri, 19 Jul 2024 00:00:00 GMT","value":50},"2022":{"data_source":"overall","date_time":"2022","definition":"overall metrics with threshold","metric":"overall","observation_id":465,"place_fips":null,"place_id":67,"place_iso":"DZ","place_name":"Algeria","stale_flag":false,"updated_at":"Fri, 19 Jul 2024 00:00:00 GMT","value":56},"2023":{"data_source":"overall","date_time":"2023","definition":"overall metrics with threshold","metric":"overall","observation_id":1427,"place_fips":null,"place_id":67,"place_iso":"DZ","place_name":"Algeria","stale_flag":false,"updated_at":"Fri, 19 Jul 2024 00:00:00 GMT","value":56},"2024":{"data_source":"overall","date_time":"2024","definition":"overall metrics with threshold","metric":"overall","observation_id":968,"place_fips":null,"place_id":67,"place_iso":"DZ","place_name":"Algeria","stale_flag":false,"updated_at":"Fri, 19 Jul 2024 00:00:00 GMT","value":56},"recent":{"data_source":"overall_recent_score_threshold","date_time":"2024","definition":"overall most recent data score threshold","metric":"overall_recent_score_threshold","observation_id":121,"place_fips":null,"place_id":67,"place_iso":"DZ","place_name":"Algeria","stale_flag":false,"updated_at":"Fri, 19 Jul 2024 00:00:00 GMT","value":54}},"policyAreaAdoption":{"2015":{"Clinical and treatment":{},"Testing and prevention":{},"Structural":{},"Health systems":{}},"2016":{"Clinical and treatment":{},"Testing and prevention":{},"Structural":{},"Health systems":{}},"2017":{"Clinical and treatment":{"null":2,"partial":1,"not adopted":1,"adopted":4},"Testing and prevention":{"partial":1,"not adopted":4,"adopted":3},"Structural":{"null":2,"partial":3,"not adopted":3,"adopted":2},"Health systems":{"null":3,"partial":1,"not adopted":3}},"2018":{"Clinical and treatment":{"null":4,"partial":1,"not adopted":1,"adopted":2},"Testing and prevention":{"null":1,"partial":1,"not adopted":4,"adopted":2},"Structural":{"null":1,"partial":3,"not adopted":3,"adopted":3},"Health systems":{"null":4,"not adopted":2,"adopted":1}},"2019":{"Clinical and treatment":{"null":4,"partial":1,"not adopted":2,"adopted":1},"Testing and prevention":{"null":1,"partial":1,"not adopted":4,"adopted":2},"Structural":{"null":1,"partial":1,"not adopted":5,"adopted":3},"Health systems":{"null":4,"not adopted":2,"adopted":1}},"2020":{"Clinical and treatment":{"null":4,"partial":1,"not adopted":1,"adopted":2},"Testing and prevention":{"null":3,"partial":2,"not adopted":2,"adopted":1},"Structural":{"null":3,"partial":1,"not adopted":3,"adopted":3},"Health systems":{"null":4,"not adopted":2,"adopted":1}},"2021":{"Clinical and treatment":{"null":7,"adopted":1},"Testing and prevention":{"null":5,"partial":1,"not adopted":1,"adopted":1},"Structural":{"null":2,"partial":1,"not adopted":4,"adopted":3},"Health systems":{"null":5,"not adopted":1,"adopted":1}},"2022":{"Clinical and treatment":{"null":7,"adopted":1},"Testing and prevention":{"null":4,"partial":1,"not adopted":1,"adopted":2},"Structural":{"null":2,"partial":1,"not adopted":4,"adopted":3},"Health systems":{"null":4,"not adopted":1,"adopted":2}},"2023":{"Clinical and treatment":{"null":7,"adopted":1},"Testing and prevention":{"null":4,"partial":1,"not adopted":1,"adopted":2},"Structural":{"null":2,"partial":1,"not adopted":4,"adopted":3},"Health systems":{"null":4,"not adopted":1,"adopted":2}},"2024":{"Clinical and treatment":{"null":7,"adopted":1},"Testing and prevention":{"null":4,"partial":1,"not adopted":1,"adopted":2},"Structural":{"null":2,"partial":1,"not adopted":4,"adopted":3},"Health systems":{"null":4,"not adopted":1,"adopted":2}},"recent":{"Clinical and treatment":{"adopted":4,"not adopted":2,"partial":1,"null":1},"Testing and prevention":{"adopted":4,"not adopted":2,"partial":2,"null":null},"Structural":{"adopted":3,"not adopted":4,"partial":2,"null":1},"Health systems":{"adopted":1,"not adopted":2,"partial":1,"null":3}}},"policyAreaScores":{"2015":{"Clinical and treatment":{},"Testing and prevention":{},"Structural":{},"Health systems":{}},"2016":{"Clinical and treatment":{},"Testing and prevention":{},"Structural":{},"Health systems":{}},"2017":{"Clinical and treatment":{"value":75},"Testing and prevention":{"value":43.75},"Structural":{"value":43.75},"Health systems":{"value":12.5}},"2018":{"Clinical and treatment":{"value":62.5},"Testing and prevention":{"value":35.7142857142857},"Structural":{"value":50},"Health systems":{"value":33.3333333333333}},"2019":{"Clinical and treatment":{"value":37.5},"Testing and prevention":{"value":35.7142857142857},"Structural":{"value":38.8888888888889},"Health systems":{"value":33.3333333333333}},"2020":{"Clinical and treatment":{"value":62.5},"Testing and prevention":{"value":40},"Structural":{"value":50},"Health systems":{"value":33.3333333333333}},"2021":{"Clinical and treatment":{"value":null},"Testing and prevention":{"value":50},"Structural":{"value":43.75},"Health systems":{"value":null}},"2022":{"Clinical and treatment":{"value":null},"Testing and prevention":{"value":62.5},"Structural":{"value":43.75},"Health systems":{"value":66.6666666666667}},"2023":{"Clinical and treatment":{"value":null},"Testing and prevention":{"value":62.5},"Structural":{"value":43.75},"Health systems":{"value":66.6666666666667}},"2024":{"Clinical and treatment":{"value":null},"Testing and prevention":{"value":62.5},"Structural":{"value":43.75},"Health systems":{"value":66.6666666666667}},"recent":{"Clinical and treatment":{"value":64.2857142857143},"Testing and prevention":{"value":62.5},"Structural":{"value":44.4444444444444},"Health systems":{"value":37.5}}},"overallAdoption":{"2015":{"adopted":0,"not adopted":0,"null":0,"partial":0},"2016":{"adopted":0,"not adopted":0,"null":0,"partial":0},"2017":{"adopted":9,"not adopted":11,"null":7,"partial":6},"2018":{"adopted":8,"not adopted":10,"null":10,"partial":5},"2019":{"adopted":7,"not adopted":13,"null":10,"partial":3},"2020":{"adopted":7,"not adopted":8,"null":14,"partial":4},"2021":{"adopted":6,"not adopted":6,"null":19,"partial":2},"2022":{"adopted":8,"not adopted":6,"null":17,"partial":2},"2023":{"adopted":8,"not adopted":6,"null":17,"partial":2},"2024":{"adopted":8,"not adopted":6,"null":17,"partial":2},"recent":{"adopted":12,"not adopted":10,"partial":6,"null":5},"years":{"adopted":0,"not adopted":0,"null":33,"partial":0}},"epiData":{"2015":{"HIV Incidence":{"value":1900},"infections Five year percent change":{"value":null},"infections compare 2015 percent change":{"value":null},"ART known treatment":{"value":79},"ART change":{"value":null},"ART treatment percent change":{"value":null},"ART treatment point change 2015":{"value":null},"HIV patients on ART":{"value":47},"HIV patients on ART 5 years":{"value":null},"HIV patients on ART 2015":{"value":null},"HIV patients on ART point change 2015":{"value":null},"HIV patients on ART point change 5 years":{"value":null}},"2016":{"HIV Incidence":{"value":1900},"infections Five year percent change":{"value":null},"infections compare 2015 percent change":{"value":null},"ART known treatment":{"value":82},"ART change":{"value":null},"ART treatment percent change":{"value":null},"ART treatment point change 2015":{"value":null},"HIV patients on ART":{"value":53},"HIV patients on ART 5 years":{"value":null},"HIV patients on ART 2015":{"value":null},"HIV patients on ART point change 2015":{"value":null},"HIV patients on ART point change 5 years":{"value":null}},"2017":{"HIV Incidence":{"value":2000},"infections Five year percent change":{"value":25},"infections compare 2015 percent change":{"value":5.3},"ART known treatment":{"value":82},"ART change":{"value":3.8},"ART treatment percent change":{"value":34.4},"ART treatment point change 2015":{"value":3},"HIV patients on ART":{"value":56},"HIV patients on ART 5 years":{"value":100},"HIV patients on ART 2015":{"value":19.1},"HIV patients on ART point change 2015":{"value":9},"HIV patients on ART point change 5 years":{"value":28}},"2018":{"HIV Incidence":{"value":2000},"infections Five year percent change":{"value":17.6},"infections compare 2015 percent change":{"value":5.3},"ART known treatment":{"value":82},"ART change":{"value":3.8},"ART treatment percent change":{"value":18.8},"ART treatment point change 2015":{"value":3},"HIV patients on ART":{"value":60},"HIV patients on ART 5 years":{"value":71.4},"HIV patients on ART 2015":{"value":27.7},"HIV patients on ART point change 2015":{"value":13},"HIV patients on ART point change 5 years":{"value":25}},"2019":{"HIV Incidence":{"value":2000},"infections Five year percent change":{"value":5.3},"infections compare 2015 percent change":{"value":5.3},"ART known treatment":{"value":83},"ART change":{"value":5.1},"ART treatment percent change":{"value":10.7},"ART treatment point change 2015":{"value":4},"HIV patients on ART":{"value":63},"HIV patients on ART 5 years":{"value":57.5},"HIV patients on ART 2015":{"value":34},"HIV patients on ART point change 2015":{"value":16},"HIV patients on ART point change 5 years":{"value":23}},"2020":{"HIV Incidence":{"value":2100},"infections Five year percent change":{"value":10.5},"infections compare 2015 percent change":{"value":10.5},"ART known treatment":{"value":82},"ART change":{"value":3.8},"ART treatment percent change":{"value":3.8},"ART treatment point change 2015":{"value":3},"HIV patients on ART":{"value":64},"HIV patients on ART 5 years":{"value":36.2},"HIV patients on ART 2015":{"value":36.2},"HIV patients on ART point change 2015":{"value":17},"HIV patients on ART point change 5 years":{"value":17}},"2021":{"HIV Incidence":{"value":2200},"infections Five year percent change":{"value":15.8},"infections compare 2015 percent change":{"value":15.8},"ART known treatment":{"value":82},"ART change":{"value":3.8},"ART treatment percent change":{"value":0},"ART treatment point change 2015":{"value":3},"HIV patients on ART":{"value":66},"HIV patients on ART 5 years":{"value":24.5},"HIV patients on ART 2015":{"value":40.4},"HIV patients on ART point change 2015":{"value":19},"HIV patients on ART point change 5 years":{"value":13}},"2022":{"HIV Incidence":{"value":2200},"infections Five year percent change":{"value":10},"infections compare 2015 percent change":{"value":15.8},"ART known treatment":{"value":79},"ART change":{"value":0},"ART treatment percent change":{"value":-3.7},"ART treatment point change 2015":{"value":0},"HIV patients on ART":{"value":63},"HIV patients on ART 5 years":{"value":12.5},"HIV patients on ART 2015":{"value":34},"HIV patients on ART point change 2015":{"value":16},"HIV patients on ART point change 5 years":{"value":7}},"2023":{},"2024":{},"recent":{"HIV Incidence":{"value":2200,"_year":"2022"},"infections Five year percent change":{"value":10,"_year":"2022"},"infections compare 2015 percent change":{"value":15.8,"_year":"2022"},"ART known treatment":{"value":79,"_year":"2022"},"ART change":{"value":0,"_year":"2022"},"ART treatment percent change":{"value":-3.7,"_year":"2022"},"ART treatment point change 2015":{"value":0,"_year":"2022"},"HIV patients on ART":{"value":63,"_year":"2022"},"HIV patients on ART 5 years":{"value":12.5,"_year":"2022"},"HIV patients on ART 2015":{"value":34,"_year":"2022"},"HIV patients on ART point change 2015":{"value":16,"_year":"2022"},"HIV patients on ART point change 5 years":{"value":7,"_year":"2022"}}},"indScores":{"2015":{},"2016":{},"2017":{"CT1":{"value":1,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":"adopted","year":"2017","id":37080,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"year":"2017","id":37081,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":1,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":"adopted","year":"2017","id":37083,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4":{"value":0.5,"code":"CT4","title":"Differentiated service delivery","descrip":"Do national HIV treatment policies include multiple options for differentiated HIV treatment services?","level":"partial","year":"2017","id":37086,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":1,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":"adopted","year":"2017","id":37090,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6":{"value":1,"code":"CT6","title":"Pediatric diagnosis & treatment","descrip":"Are national pediatric testing and treatment policies aligned with international recommendations?","level":"adopted","year":"2017","id":37095,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7":{"value":null,"code":"CT7","title":"Migrants access to healthcare","descrip":"Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":null,"year":"2017","id":37101,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":0,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":"not adopted","year":"2017","id":37108,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","year":"2017","id":37116,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2":{"value":1,"code":"TP2","title":"Partner notification/Index testing","descrip":"Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?","level":"adopted","year":"2017","id":37125,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":1,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":"adopted","year":"2017","id":37135,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":0,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":"not adopted","year":"2017","id":37146,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5":{"value":0.5,"code":"TP5","title":"PrEP","descrip":"Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?","level":"partial","year":"2017","id":37158,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6":{"value":1,"code":"TP6","title":"Harm reduction","descrip":"Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?","level":"adopted","year":"2017","id":37171,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":0,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":"not adopted","year":"2017","id":37185,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8":{"value":0,"code":"TP8","title":"Prisoners prevention","descrip":"Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?","level":"not adopted","year":"2017","id":37200,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1":{"value":0.5,"code":"S1","title":"Same-sex sex non-criminalization","descrip":"Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?","level":"partial","year":"2017","id":37216,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","year":"2017","id":37233,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","year":"2017","id":37251,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4":{"value":1,"code":"S4","title":"HIV exposure non-criminalization","descrip":"Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?","level":"adopted","year":"2017","id":37270,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5":{"value":0,"code":"S5","title":"Non-discrimination protections","descrip":"Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?","level":"not adopted","year":"2017","id":37290,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","year":"2017","id":37311,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":null,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":null,"year":"2017","id":37333,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"year":"2017","id":37356,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","year":"2017","id":37380,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10":{"value":0.5,"code":"S10","title":"Civil society","descrip":"Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?","level":"partial","year":"2017","id":37405,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":0,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":"not adopted","year":"2017","id":37431,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2":{"value":0.5,"code":"HS2","title":"Health financing","descrip":"Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?","level":"partial","year":"2017","id":37458,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3":{"value":null,"code":"HS3","title":"Universal health coverage","descrip":"Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?","level":null,"year":"2017","id":37486,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4":{"value":null,"code":"HS4","title":"User fees","descrip":"Are public primary healthcare and HIV services available without user fees at the point of service under national policy?","level":null,"year":"2017","id":37515,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5":{"value":0,"code":"HS5","title":"Access to medicines (TRIPS)","descrip":"Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?","level":"not adopted","year":"2017","id":37545,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6":{"value":0,"code":"HS6","title":"Unique identifiers with  data protections","descrip":"Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?","level":"not adopted","year":"2017","id":37576,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7":{"value":null,"code":"HS7","title":"Data sharing","descrip":"Is it national policy to publicly share disaggregated HIV data on a regular basis?","level":null,"year":"2017","id":37608,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2018":{"CT1":{"value":1,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":"adopted","year":"2018","id":37608,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"year":"2018","id":37609,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"year":"2018","id":37611,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4":{"value":0.5,"code":"CT4","title":"Differentiated service delivery","descrip":"Do national HIV treatment policies include multiple options for differentiated HIV treatment services?","level":"partial","year":"2018","id":37614,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":1,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":"adopted","year":"2018","id":37618,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6":{"value":null,"code":"CT6","title":"Pediatric diagnosis & treatment","descrip":"Are national pediatric testing and treatment policies aligned with international recommendations?","level":null,"year":"2018","id":37623,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7":{"value":null,"code":"CT7","title":"Migrants access to healthcare","descrip":"Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":null,"year":"2018","id":37629,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":0,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":"not adopted","year":"2018","id":37636,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","year":"2018","id":37644,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2":{"value":1,"code":"TP2","title":"Partner notification/Index testing","descrip":"Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?","level":"adopted","year":"2018","id":37653,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":1,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":"adopted","year":"2018","id":37663,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":0,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":"not adopted","year":"2018","id":37674,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5":{"value":0.5,"code":"TP5","title":"PrEP","descrip":"Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?","level":"partial","year":"2018","id":37686,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6":{"value":0,"code":"TP6","title":"Harm reduction","descrip":"Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?","level":"not adopted","year":"2018","id":37699,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"year":"2018","id":37713,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8":{"value":0,"code":"TP8","title":"Prisoners prevention","descrip":"Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?","level":"not adopted","year":"2018","id":37728,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1":{"value":0.5,"code":"S1","title":"Same-sex sex non-criminalization","descrip":"Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?","level":"partial","year":"2018","id":37744,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","year":"2018","id":37761,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","year":"2018","id":37779,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4":{"value":1,"code":"S4","title":"HIV exposure non-criminalization","descrip":"Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?","level":"adopted","year":"2018","id":37798,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5":{"value":0,"code":"S5","title":"Non-discrimination protections","descrip":"Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?","level":"not adopted","year":"2018","id":37818,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","year":"2018","id":37839,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","year":"2018","id":37861,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"year":"2018","id":37884,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","year":"2018","id":37908,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10":{"value":0.5,"code":"S10","title":"Civil society","descrip":"Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?","level":"partial","year":"2018","id":37933,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"year":"2018","id":37959,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2":{"value":1,"code":"HS2","title":"Health financing","descrip":"Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?","level":"adopted","year":"2018","id":37986,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3":{"value":null,"code":"HS3","title":"Universal health coverage","descrip":"Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?","level":null,"year":"2018","id":38014,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4":{"value":null,"code":"HS4","title":"User fees","descrip":"Are public primary healthcare and HIV services available without user fees at the point of service under national policy?","level":null,"year":"2018","id":38043,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5":{"value":0,"code":"HS5","title":"Access to medicines (TRIPS)","descrip":"Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?","level":"not adopted","year":"2018","id":38073,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6":{"value":0,"code":"HS6","title":"Unique identifiers with  data protections","descrip":"Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?","level":"not adopted","year":"2018","id":38104,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7":{"value":null,"code":"HS7","title":"Data sharing","descrip":"Is it national policy to publicly share disaggregated HIV data on a regular basis?","level":null,"year":"2018","id":38136,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2019":{"CT1":{"value":1,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":"adopted","year":"2019","id":38136,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"year":"2019","id":38137,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":0,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":"not adopted","year":"2019","id":38139,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4":{"value":0.5,"code":"CT4","title":"Differentiated service delivery","descrip":"Do national HIV treatment policies include multiple options for differentiated HIV treatment services?","level":"partial","year":"2019","id":38142,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"year":"2019","id":38146,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6":{"value":null,"code":"CT6","title":"Pediatric diagnosis & treatment","descrip":"Are national pediatric testing and treatment policies aligned with international recommendations?","level":null,"year":"2019","id":38151,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7":{"value":null,"code":"CT7","title":"Migrants access to healthcare","descrip":"Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":null,"year":"2019","id":38157,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":0,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":"not adopted","year":"2019","id":38164,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","year":"2019","id":38172,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2":{"value":1,"code":"TP2","title":"Partner notification/Index testing","descrip":"Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?","level":"adopted","year":"2019","id":38181,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"year":"2019","id":38191,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":0,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":"not adopted","year":"2019","id":38202,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5":{"value":0.5,"code":"TP5","title":"PrEP","descrip":"Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?","level":"partial","year":"2019","id":38214,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6":{"value":0,"code":"TP6","title":"Harm reduction","descrip":"Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?","level":"not adopted","year":"2019","id":38227,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":1,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":"adopted","year":"2019","id":38241,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8":{"value":0,"code":"TP8","title":"Prisoners prevention","descrip":"Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?","level":"not adopted","year":"2019","id":38256,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1":{"value":0,"code":"S1","title":"Same-sex sex non-criminalization","descrip":"Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?","level":"not adopted","year":"2019","id":38272,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","year":"2019","id":38289,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","year":"2019","id":38307,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4":{"value":1,"code":"S4","title":"HIV exposure non-criminalization","descrip":"Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?","level":"adopted","year":"2019","id":38326,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5":{"value":0,"code":"S5","title":"Non-discrimination protections","descrip":"Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?","level":"not adopted","year":"2019","id":38346,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","year":"2019","id":38367,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","year":"2019","id":38389,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"year":"2019","id":38412,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","year":"2019","id":38436,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10":{"value":0,"code":"S10","title":"Civil society","descrip":"Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?","level":"not adopted","year":"2019","id":38461,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"year":"2019","id":38487,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2":{"value":1,"code":"HS2","title":"Health financing","descrip":"Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?","level":"adopted","year":"2019","id":38514,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3":{"value":null,"code":"HS3","title":"Universal health coverage","descrip":"Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?","level":null,"year":"2019","id":38542,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4":{"value":null,"code":"HS4","title":"User fees","descrip":"Are public primary healthcare and HIV services available without user fees at the point of service under national policy?","level":null,"year":"2019","id":38571,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5":{"value":0,"code":"HS5","title":"Access to medicines (TRIPS)","descrip":"Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?","level":"not adopted","year":"2019","id":38601,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6":{"value":0,"code":"HS6","title":"Unique identifiers with  data protections","descrip":"Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?","level":"not adopted","year":"2019","id":38632,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7":{"value":null,"code":"HS7","title":"Data sharing","descrip":"Is it national policy to publicly share disaggregated HIV data on a regular basis?","level":null,"year":"2019","id":38664,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2020":{"CT1":{"value":1,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":"adopted","year":"2020","id":38664,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"year":"2020","id":38665,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"year":"2020","id":38667,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4":{"value":0.5,"code":"CT4","title":"Differentiated service delivery","descrip":"Do national HIV treatment policies include multiple options for differentiated HIV treatment services?","level":"partial","year":"2020","id":38670,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"year":"2020","id":38674,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6":{"value":null,"code":"CT6","title":"Pediatric diagnosis & treatment","descrip":"Are national pediatric testing and treatment policies aligned with international recommendations?","level":null,"year":"2020","id":38679,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7":{"value":1,"code":"CT7","title":"Migrants access to healthcare","descrip":"Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","year":"2020","id":38685,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":0,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":"not adopted","year":"2020","id":38692,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","year":"2020","id":38700,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2":{"value":1,"code":"TP2","title":"Partner notification/Index testing","descrip":"Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?","level":"adopted","year":"2020","id":38709,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"year":"2020","id":38719,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":null,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":null,"year":"2020","id":38730,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5":{"value":0.5,"code":"TP5","title":"PrEP","descrip":"Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?","level":"partial","year":"2020","id":38742,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6":{"value":0,"code":"TP6","title":"Harm reduction","descrip":"Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?","level":"not adopted","year":"2020","id":38755,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"year":"2020","id":38769,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8":{"value":0.5,"code":"TP8","title":"Prisoners prevention","descrip":"Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?","level":"partial","year":"2020","id":38784,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1":{"value":0,"code":"S1","title":"Same-sex sex non-criminalization","descrip":"Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?","level":"not adopted","year":"2020","id":38800,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","year":"2020","id":38817,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":null,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":null,"year":"2020","id":38835,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4":{"value":1,"code":"S4","title":"HIV exposure non-criminalization","descrip":"Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?","level":"adopted","year":"2020","id":38854,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5":{"value":null,"code":"S5","title":"Non-discrimination protections","descrip":"Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?","level":null,"year":"2020","id":38874,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","year":"2020","id":38895,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","year":"2020","id":38917,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"year":"2020","id":38940,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","year":"2020","id":38964,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10":{"value":0,"code":"S10","title":"Civil society","descrip":"Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?","level":"not adopted","year":"2020","id":38989,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"year":"2020","id":39015,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2":{"value":1,"code":"HS2","title":"Health financing","descrip":"Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?","level":"adopted","year":"2020","id":39042,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3":{"value":null,"code":"HS3","title":"Universal health coverage","descrip":"Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?","level":null,"year":"2020","id":39070,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4":{"value":null,"code":"HS4","title":"User fees","descrip":"Are public primary healthcare and HIV services available without user fees at the point of service under national policy?","level":null,"year":"2020","id":39099,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5":{"value":0,"code":"HS5","title":"Access to medicines (TRIPS)","descrip":"Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?","level":"not adopted","year":"2020","id":39129,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6":{"value":0,"code":"HS6","title":"Unique identifiers with  data protections","descrip":"Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?","level":"not adopted","year":"2020","id":39160,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7":{"value":null,"code":"HS7","title":"Data sharing","descrip":"Is it national policy to publicly share disaggregated HIV data on a regular basis?","level":null,"year":"2020","id":39192,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2021":{"CT1":{"value":null,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":null,"year":"2021","id":39192,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"year":"2021","id":39193,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"year":"2021","id":39195,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4":{"value":null,"code":"CT4","title":"Differentiated service delivery","descrip":"Do national HIV treatment policies include multiple options for differentiated HIV treatment services?","level":null,"year":"2021","id":39198,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"year":"2021","id":39202,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6":{"value":null,"code":"CT6","title":"Pediatric diagnosis & treatment","descrip":"Are national pediatric testing and treatment policies aligned with international recommendations?","level":null,"year":"2021","id":39207,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7":{"value":1,"code":"CT7","title":"Migrants access to healthcare","descrip":"Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","year":"2021","id":39213,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":null,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":null,"year":"2021","id":39220,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","year":"2021","id":39228,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2":{"value":null,"code":"TP2","title":"Partner notification/Index testing","descrip":"Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?","level":null,"year":"2021","id":39237,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"year":"2021","id":39247,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":null,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":null,"year":"2021","id":39258,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5":{"value":0.5,"code":"TP5","title":"PrEP","descrip":"Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?","level":"partial","year":"2021","id":39270,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6":{"value":null,"code":"TP6","title":"Harm reduction","descrip":"Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?","level":null,"year":"2021","id":39283,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"year":"2021","id":39297,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8":{"value":1,"code":"TP8","title":"Prisoners prevention","descrip":"Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?","level":"adopted","year":"2021","id":39312,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1":{"value":0,"code":"S1","title":"Same-sex sex non-criminalization","descrip":"Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?","level":"not adopted","year":"2021","id":39328,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","year":"2021","id":39345,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","year":"2021","id":39363,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4":{"value":1,"code":"S4","title":"HIV exposure non-criminalization","descrip":"Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?","level":"adopted","year":"2021","id":39382,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5":{"value":null,"code":"S5","title":"Non-discrimination protections","descrip":"Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?","level":null,"year":"2021","id":39402,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","year":"2021","id":39423,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","year":"2021","id":39445,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"year":"2021","id":39468,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","year":"2021","id":39492,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10":{"value":0,"code":"S10","title":"Civil society","descrip":"Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?","level":"not adopted","year":"2021","id":39517,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"year":"2021","id":39543,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2":{"value":1,"code":"HS2","title":"Health financing","descrip":"Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?","level":"adopted","year":"2021","id":39570,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3":{"value":null,"code":"HS3","title":"Universal health coverage","descrip":"Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?","level":null,"year":"2021","id":39598,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4":{"value":null,"code":"HS4","title":"User fees","descrip":"Are public primary healthcare and HIV services available without user fees at the point of service under national policy?","level":null,"year":"2021","id":39627,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5":{"value":0,"code":"HS5","title":"Access to medicines (TRIPS)","descrip":"Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?","level":"not adopted","year":"2021","id":39657,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6":{"value":null,"code":"HS6","title":"Unique identifiers with  data protections","descrip":"Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?","level":null,"year":"2021","id":39688,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7":{"value":null,"code":"HS7","title":"Data sharing","descrip":"Is it national policy to publicly share disaggregated HIV data on a regular basis?","level":null,"year":"2021","id":39720,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2022":{"CT1":{"value":null,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":null,"year":"2022","id":39720,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"year":"2022","id":39721,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"year":"2022","id":39723,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4":{"value":null,"code":"CT4","title":"Differentiated service delivery","descrip":"Do national HIV treatment policies include multiple options for differentiated HIV treatment services?","level":null,"year":"2022","id":39726,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"year":"2022","id":39730,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6":{"value":null,"code":"CT6","title":"Pediatric diagnosis & treatment","descrip":"Are national pediatric testing and treatment policies aligned with international recommendations?","level":null,"year":"2022","id":39735,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7":{"value":1,"code":"CT7","title":"Migrants access to healthcare","descrip":"Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","year":"2022","id":39741,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":null,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":null,"year":"2022","id":39748,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","year":"2022","id":39756,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2":{"value":null,"code":"TP2","title":"Partner notification/Index testing","descrip":"Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?","level":null,"year":"2022","id":39765,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"year":"2022","id":39775,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":null,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":null,"year":"2022","id":39786,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5":{"value":0.5,"code":"TP5","title":"PrEP","descrip":"Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?","level":"partial","year":"2022","id":39798,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6":{"value":1,"code":"TP6","title":"Harm reduction","descrip":"Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?","level":"adopted","year":"2022","id":39811,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"year":"2022","id":39825,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8":{"value":1,"code":"TP8","title":"Prisoners prevention","descrip":"Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?","level":"adopted","year":"2022","id":39840,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1":{"value":0,"code":"S1","title":"Same-sex sex non-criminalization","descrip":"Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?","level":"not adopted","year":"2022","id":39856,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","year":"2022","id":39873,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","year":"2022","id":39891,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4":{"value":1,"code":"S4","title":"HIV exposure non-criminalization","descrip":"Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?","level":"adopted","year":"2022","id":39910,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5":{"value":null,"code":"S5","title":"Non-discrimination protections","descrip":"Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?","level":null,"year":"2022","id":39930,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","year":"2022","id":39951,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","year":"2022","id":39973,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"year":"2022","id":39996,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","year":"2022","id":40020,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10":{"value":0,"code":"S10","title":"Civil society","descrip":"Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?","level":"not adopted","year":"2022","id":40045,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"year":"2022","id":40071,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2":{"value":1,"code":"HS2","title":"Health financing","descrip":"Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?","level":"adopted","year":"2022","id":40098,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3":{"value":null,"code":"HS3","title":"Universal health coverage","descrip":"Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?","level":null,"year":"2022","id":40126,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4":{"value":null,"code":"HS4","title":"User fees","descrip":"Are public primary healthcare and HIV services available without user fees at the point of service under national policy?","level":null,"year":"2022","id":40155,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5":{"value":0,"code":"HS5","title":"Access to medicines (TRIPS)","descrip":"Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?","level":"not adopted","year":"2022","id":40185,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6":{"value":1,"code":"HS6","title":"Unique identifiers with  data protections","descrip":"Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?","level":"adopted","year":"2022","id":40216,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7":{"value":null,"code":"HS7","title":"Data sharing","descrip":"Is it national policy to publicly share disaggregated HIV data on a regular basis?","level":null,"year":"2022","id":40248,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2023":{"CT1":{"value":null,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":null,"year":"2023","id":40248,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"year":"2023","id":40249,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"year":"2023","id":40251,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4":{"value":null,"code":"CT4","title":"Differentiated service delivery","descrip":"Do national HIV treatment policies include multiple options for differentiated HIV treatment services?","level":null,"year":"2023","id":40254,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"year":"2023","id":40258,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6":{"value":null,"code":"CT6","title":"Pediatric diagnosis & treatment","descrip":"Are national pediatric testing and treatment policies aligned with international recommendations?","level":null,"year":"2023","id":40263,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7":{"value":1,"code":"CT7","title":"Migrants access to healthcare","descrip":"Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","year":"2023","id":40269,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":null,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":null,"year":"2023","id":40276,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","year":"2023","id":40284,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2":{"value":null,"code":"TP2","title":"Partner notification/Index testing","descrip":"Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?","level":null,"year":"2023","id":40293,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"year":"2023","id":40303,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":null,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":null,"year":"2023","id":40314,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5":{"value":0.5,"code":"TP5","title":"PrEP","descrip":"Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?","level":"partial","year":"2023","id":40326,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6":{"value":1,"code":"TP6","title":"Harm reduction","descrip":"Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?","level":"adopted","year":"2023","id":40339,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"year":"2023","id":40353,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8":{"value":1,"code":"TP8","title":"Prisoners prevention","descrip":"Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?","level":"adopted","year":"2023","id":40368,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1":{"value":0,"code":"S1","title":"Same-sex sex non-criminalization","descrip":"Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?","level":"not adopted","year":"2023","id":40384,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","year":"2023","id":40401,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","year":"2023","id":40419,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4":{"value":1,"code":"S4","title":"HIV exposure non-criminalization","descrip":"Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?","level":"adopted","year":"2023","id":40438,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5":{"value":null,"code":"S5","title":"Non-discrimination protections","descrip":"Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?","level":null,"year":"2023","id":40458,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","year":"2023","id":40479,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","year":"2023","id":40501,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"year":"2023","id":40524,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","year":"2023","id":40548,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10":{"value":0,"code":"S10","title":"Civil society","descrip":"Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?","level":"not adopted","year":"2023","id":40573,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"year":"2023","id":40599,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2":{"value":1,"code":"HS2","title":"Health financing","descrip":"Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?","level":"adopted","year":"2023","id":40626,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3":{"value":null,"code":"HS3","title":"Universal health coverage","descrip":"Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?","level":null,"year":"2023","id":40654,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4":{"value":null,"code":"HS4","title":"User fees","descrip":"Are public primary healthcare and HIV services available without user fees at the point of service under national policy?","level":null,"year":"2023","id":40683,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5":{"value":0,"code":"HS5","title":"Access to medicines (TRIPS)","descrip":"Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?","level":"not adopted","year":"2023","id":40713,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6":{"value":1,"code":"HS6","title":"Unique identifiers with  data protections","descrip":"Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?","level":"adopted","year":"2023","id":40744,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7":{"value":null,"code":"HS7","title":"Data sharing","descrip":"Is it national policy to publicly share disaggregated HIV data on a regular basis?","level":null,"year":"2023","id":40776,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"2024":{"CT1":{"value":null,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":null,"year":"2024","id":40776,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"year":"2024","id":40777,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":null,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":null,"year":"2024","id":40779,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4":{"value":null,"code":"CT4","title":"Differentiated service delivery","descrip":"Do national HIV treatment policies include multiple options for differentiated HIV treatment services?","level":null,"year":"2024","id":40782,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":null,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":null,"year":"2024","id":40786,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6":{"value":null,"code":"CT6","title":"Pediatric diagnosis & treatment","descrip":"Are national pediatric testing and treatment policies aligned with international recommendations?","level":null,"year":"2024","id":40791,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7":{"value":1,"code":"CT7","title":"Migrants access to healthcare","descrip":"Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","year":"2024","id":40797,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":null,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":null,"year":"2024","id":40804,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","year":"2024","id":40812,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2":{"value":null,"code":"TP2","title":"Partner notification/Index testing","descrip":"Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?","level":null,"year":"2024","id":40821,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":null,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":null,"year":"2024","id":40831,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":null,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":null,"year":"2024","id":40842,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5":{"value":0.5,"code":"TP5","title":"PrEP","descrip":"Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?","level":"partial","year":"2024","id":40854,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6":{"value":1,"code":"TP6","title":"Harm reduction","descrip":"Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?","level":"adopted","year":"2024","id":40867,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":null,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":null,"year":"2024","id":40881,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8":{"value":1,"code":"TP8","title":"Prisoners prevention","descrip":"Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?","level":"adopted","year":"2024","id":40896,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1":{"value":0,"code":"S1","title":"Same-sex sex non-criminalization","descrip":"Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?","level":"not adopted","year":"2024","id":40912,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","year":"2024","id":40929,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","year":"2024","id":40947,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4":{"value":1,"code":"S4","title":"HIV exposure non-criminalization","descrip":"Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?","level":"adopted","year":"2024","id":40966,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5":{"value":null,"code":"S5","title":"Non-discrimination protections","descrip":"Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?","level":null,"year":"2024","id":40986,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","year":"2024","id":41007,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","year":"2024","id":41029,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"year":"2024","id":41052,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","year":"2024","id":41076,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10":{"value":0,"code":"S10","title":"Civil society","descrip":"Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?","level":"not adopted","year":"2024","id":41101,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":null,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":null,"year":"2024","id":41127,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2":{"value":1,"code":"HS2","title":"Health financing","descrip":"Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?","level":"adopted","year":"2024","id":41154,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3":{"value":null,"code":"HS3","title":"Universal health coverage","descrip":"Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?","level":null,"year":"2024","id":41182,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4":{"value":null,"code":"HS4","title":"User fees","descrip":"Are public primary healthcare and HIV services available without user fees at the point of service under national policy?","level":null,"year":"2024","id":41211,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5":{"value":0,"code":"HS5","title":"Access to medicines (TRIPS)","descrip":"Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?","level":"not adopted","year":"2024","id":41241,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6":{"value":1,"code":"HS6","title":"Unique identifiers with  data protections","descrip":"Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?","level":"adopted","year":"2024","id":41272,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7":{"value":null,"code":"HS7","title":"Data sharing","descrip":"Is it national policy to publicly share disaggregated HIV data on a regular basis?","level":null,"year":"2024","id":41304,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}},"years":{"CT1":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT2":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT3":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT4":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT5":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT6":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT7":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"CT8":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP1":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP2":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP3":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP4":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP5":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP6":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP7":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"TP8":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S1":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S2":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S3":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S4":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S5":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S6":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S7":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S8":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S9":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"S10":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS1":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS2":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS3":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS4":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS5":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"yes"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS6":[{"year":"2024","data":"yes"},{"year":"2023","data":"yes"},{"year":"2022","data":"yes"},{"year":"2021","data":"no"},{"year":"2020","data":"yes"},{"year":"2019","data":"yes"},{"year":"2018","data":"yes"},{"year":"2017","data":"yes"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}],"HS7":[{"year":"2024","data":"no"},{"year":"2023","data":"no"},{"year":"2022","data":"no"},{"year":"2021","data":"no"},{"year":"2020","data":"no"},{"year":"2019","data":"no"},{"year":"2018","data":"no"},{"year":"2017","data":"no"},{"year":"2016","data":"no"},{"year":"2015","data":"no"}]},"recent":{"CT1":{"value":1,"code":"CT1","title":"Treatment initiation","descrip":"Are all people living with HIV, regardless of CD4 count, eligible to start HIV treatment in national policy?","level":"adopted","year":"2024","id":41832,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT2":{"value":null,"code":"CT2","title":"Same-day treatment start","descrip":"Is the option to start treatment the same day as HIV diagnosis included in national policy?","level":null,"year":"2024","id":41833,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT3":{"value":0,"code":"CT3","title":"Treatment regimen","descrip":"Are up-to-date first-line ARV regimens  aligned with international recommendations included in national HIV policy?","level":"not adopted","year":"2024","id":41835,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT4":{"value":0.5,"code":"CT4","title":"Differentiated service delivery","descrip":"Do national HIV treatment policies include multiple options for differentiated HIV treatment services?","level":"partial","year":"2024","id":41838,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT5":{"value":1,"code":"CT5","title":"Viral load testing","descrip":"Is viral load monitoring at least once per year provided for in national policy?","level":"adopted","year":"2024","id":41842,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT6":{"value":1,"code":"CT6","title":"Pediatric diagnosis & treatment","descrip":"Are national pediatric testing and treatment policies aligned with international recommendations?","level":"adopted","year":"2024","id":41847,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT7":{"value":1,"code":"CT7","title":"Migrants access to healthcare","descrip":"Are HIV services and primary healthcare available to all migrants under the same conditions as citizens under national policy?","level":"adopted","year":"2024","id":41853,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"CT8":{"value":0,"code":"CT8","title":"TB diagnostics","descrip":"Are rapid diagnostic tests (e.g. rapid molecular diagnostics, TB-LAM) aligned with WHO recommendations used as the initial diagnostic test for TB in PLHIV under national policy?","level":"not adopted","year":"2024","id":41860,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP1":{"value":0,"code":"TP1","title":"Self-testing","descrip":"Is self-testing approved in national policy?","level":"not adopted","year":"2024","id":41868,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP2":{"value":1,"code":"TP2","title":"Partner notification/Index testing","descrip":"Is index testing/partner notification, with robust protections for patient confidentiality, provided for in national policy?","level":"adopted","year":"2024","id":41877,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP3":{"value":1,"code":"TP3","title":"Compulsory testing","descrip":"Is compulsory HIV testing prohibited under national law?","level":"adopted","year":"2024","id":41887,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP4":{"value":0,"code":"TP4","title":"Age restrictions on testing & treatment","descrip":"Can adolescents access HIV testing and treatment without parental consent under national policy?","level":"not adopted","year":"2024","id":41898,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP5":{"value":0.5,"code":"TP5","title":"PrEP","descrip":"Are all people/populations at substantial risk of HIV infection eligible for PrEP under national policy and have technologies for pre-exposure prophylaxis (PrEP) received national regulatory approval?","level":"partial","year":"2024","id":41910,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP6":{"value":1,"code":"TP6","title":"Harm reduction","descrip":"Does national law and HIV policy incorporate key harm reduction strategies, including avoidance of criminalizing syringe possession?","level":"adopted","year":"2024","id":41923,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP7":{"value":1,"code":"TP7","title":"Comprehensive sexuality education","descrip":"Is comprehensive sexuality education required in primary and secondary schools under national policy?","level":"adopted","year":"2024","id":41937,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"TP8":{"value":0.5,"code":"TP8","title":"Prisoners prevention","descrip":"Are both condoms/lubricants and syringe access/exchange programs available to prisoners as a matter of policy?","level":"partial","year":"2024","id":41952,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S1":{"value":0,"code":"S1","title":"Same-sex sex non-criminalization","descrip":"Does national law/policy refrain from criminalizing and prosecuting people for consensual same-sex sexual acts?","level":"not adopted","year":"2024","id":41968,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S2":{"value":0,"code":"S2","title":"Sex work non-criminalization","descrip":"Does national law avoid criminalizing sex work (buying, selling, and organizing of sex work)?","level":"not adopted","year":"2024","id":41985,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S3":{"value":0,"code":"S3","title":"Drug use non-criminalization","descrip":"Does national law refrain from criminalizing personal drug use/possession?","level":"not adopted","year":"2024","id":42003,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S4":{"value":1,"code":"S4","title":"HIV exposure non-criminalization","descrip":"Does national law refrain from criminalizing and prosecuting people for HIV exposure/ transmission?","level":"adopted","year":"2024","id":42022,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S5":{"value":0,"code":"S5","title":"Non-discrimination protections","descrip":"Do national laws/policies include protections from discrimination on the basis of sexual orientation, gender identity, and HIV status?","level":"not adopted","year":"2024","id":42042,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S6":{"value":0.5,"code":"S6","title":"National human rights institutions","descrip":"Is there an independent national human rights institution to which violations can be reported?","level":"partial","year":"2024","id":42063,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S7":{"value":1,"code":"S7","title":"Constitutional right to health","descrip":"Is there an enforceable right to health in the national constitution?","level":"adopted","year":"2024","id":42085,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S8":{"value":null,"code":"S8","title":"Girls education","descrip":"Is there a national policy in place to encourage secondary school retention among girls?","level":null,"year":"2024","id":42108,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S9":{"value":1,"code":"S9","title":"Gender based violence","descrip":"Does the law explicitly address domestic violence with enforceable penalties?","level":"adopted","year":"2024","id":42132,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"S10":{"value":0.5,"code":"S10","title":"Civil society","descrip":"Are NGOs/CSOs able to register, seek funding and operate freely under national law and is there a social contracting policy for financing NGOs/CSO-provided services?","level":"partial","year":"2024","id":42157,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS1":{"value":0,"code":"HS1","title":"Task shifting","descrip":"Are nurses or other non-physicians allowed to initiate HIV treatment under national policy?","level":"not adopted","year":"2024","id":42183,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS2":{"value":1,"code":"HS2","title":"Health financing","descrip":"Does the national budget and fiscal policy include sufficient health spending and adequate tax revenues to meet international targets?","level":"adopted","year":"2024","id":42210,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS3":{"value":null,"code":"HS3","title":"Universal health coverage","descrip":"Does national health coverage include medications for HIV treatment & pre-exposure prophylaxis (PrEP)?","level":null,"year":"2024","id":42238,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS4":{"value":null,"code":"HS4","title":"User fees","descrip":"Are public primary healthcare and HIV services available without user fees at the point of service under national policy?","level":null,"year":"2024","id":42267,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS5":{"value":0,"code":"HS5","title":"Access to medicines (TRIPS)","descrip":"Does national law/policy take advantage of TRIPS flexibilities for affordable medicines?","level":"not adopted","year":"2024","id":42297,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS6":{"value":0.5,"code":"HS6","title":"Unique identifiers with  data protections","descrip":"Are unique identifiers for continuity of care across multiple facilities included in national policy along with protections for patients' privacy?","level":"partial","year":"2024","id":42328,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false},"HS7":{"value":null,"code":"HS7","title":"Data sharing","descrip":"Is it national policy to publicly share disaggregated HIV data on a regular basis?","level":null,"year":"2024","id":42360,"has_subs":true,"type":"Indicator","iso2":"dz","place_name":"Algeria","region":"Middle East and North Africa","is_pepfar":false}}},"region":"Middle East and North Africa","is_pepfar":false}},"staticQueryHashes":["63159454"]}